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Transcriptional Control And Development Of Energy Burning Adipocytes
Abstract
Obesity is a major driver of medical morbidity worldwide by promoting the pathogenesis of diabetes
mellitus, cardiovascular disease and nonalcoholic fatty liver disease. Obesity is fundamentally a disorder
of energy balance with energy intake chronically exceeding energy expenditure. There exists an urgent
need to understand pathways in vivo that can be coopted to increase energy expenditure in a specific
manner. One organ in small mammals and humans that expends large amounts of energy is thermogenic
adipose tissue. Genetic models in rodents and environmental perturbations in humans have identified an
important role for this tissue in controlling insulin sensitivity and energy expenditure. Thermogenic
adipocytes develop during stereotyped periods during embryogenesis are their activity is controlled
postnatally by environmental factors such as cold exposure. This thesis work is comprised of two studies
that sought to determine how transcription factors that control thermogenic adipocyte development to
facilitate environmental responsiveness and what specific cells develop into thermogenic adipocytes in
vivo. In the first study we used in vivo genetic loss of function studies, metabolic phenotyping, and
transcription factor reporter assays to identify that activity of Early B Cell Factors are required for the
basal and cold-stimulated thermogenic program in brown adipose tissue by controlling the activity and
expression of cold-induced transcription factors. This study linked regulators that had traditionally been
studied in the development of thermogenic adipocytes to the factors that control the cold-induced
thermogenic program. In the second study, we determined the developmental and maintenance structure
of perivascular adipose tissue, a thermogenic adipose depot present in small mammals and humans. We
discovered that this lineage initially develops from a fibroblastic lineage and identified a novel adipogenic
adventitial smooth muscle cell present in adulthood that has the capacity to generate adipocytes in vitro
and in vivo. Taken together, these two studies have identified the key factors required for controlling
thermogenic gene transcription in brown adipocytes and the precise progenitor cells for making
thermogenic adipocytes in vivo.
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ABSTRACT

TRANSCRIPTIONAL CONTROL AND DEVELOPMENT OF ENERGY BURNING
ADIPOCYTES
Anthony R. Angueira
Patrick Seale, PhD
Obesity is a major driver of medical morbidity worldwide by promoting the
pathogenesis of diabetes mellitus, cardiovascular disease and nonalcoholic fatty liver
disease. Obesity is fundamentally a disorder of energy balance with energy intake
chronically exceeding energy expenditure. There exists an urgent need to understand
pathways in vivo that can be coopted to increase energy expenditure in a specific manner.
One organ in small mammals and humans that expends large amounts of energy is
thermogenic adipose tissue. Genetic models in rodents and environmental perturbations
in humans have identified an important role for this tissue in controlling insulin sensitivity
and energy expenditure. Thermogenic adipocytes develop during stereotyped periods
during embryogenesis are their activity is controlled postnatally by environmental factors
such as cold exposure. This thesis work is comprised of two studies that sought to
determine how transcription factors that control thermogenic adipocyte development to
facilitate environmental responsiveness and what specific cells develop into thermogenic
adipocytes in vivo. In the first study we used in vivo genetic loss of function studies,
metabolic phenotyping, and transcription factor reporter assays to identify that activity of
Early B Cell Factors are required for the basal and cold-stimulated thermogenic program
in brown adipose tissue by controlling the activity and expression of cold-induced
transcription factors. This study linked regulators that had traditionally been studied in the
development of thermogenic adipocytes to the factors that control the cold-induced
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thermogenic program. In the second study, we determined the developmental and
maintenance structure of perivascular adipose tissue, a thermogenic adipose depot
present in small mammals and humans. We discovered that this lineage initially develops
from a fibroblastic lineage and identified a novel adipogenic adventitial smooth muscle cell
present in adulthood that has the capacity to generate adipocytes in vitro and in vivo.
Taken together, these two studies have identified the key factors required for controlling
thermogenic gene transcription in brown adipocytes and the precise progenitor cells for
making thermogenic adipocytes in vivo.
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CHAPTER 1: INTRODUCTION
ADIPOSE TISSUE AND REGULATION OF ENERGY BALANCE
Obesity is responsible for medical morbidity by contributing to a multitude of
conditions including cardiovascular disease, diabetes mellitus and nonalcoholic fatty liver
disease. Notably, obesity has also been associated with poor outcomes in hospitalized
patients infected with the novel coronavirus, SARS-Cov2 (Bello-Chavolla et al., 2020).
Obesity is a disorder of altered energy balance with energy intake chronically exceeding
energy expenditure. An inability to safely partition this excess energy in adipose tissue
drives disease pathogenesis in organs including the skeletal muscle and liver (Shulman,
2014). Much of the current therapeutics that alter energy balance suppress food intake,
which have a variety of unpalatable side effects, including nausea (Bettge et al., 2017;
Borner et al., 2020). On the other hand, few, if any, therapeutics increase energy
expenditure in a specific manner. Systemic administration of uncoupling agents and
attempts at pharmacologically increasing energy-burning adipose tissue mass in humans
have been hamstrung by cardiovascular side effects (Cheung et al., 2013a; Cypess et al.,
2015). An ideal therapeutic agent to increase energy expenditure would modulate the
activity of a physiologically active pathway and take advantage of the specificity of this
response to safely change energy balance. Therefore, my thesis work sought to
understand how a naturally occurring form of energy burning adipose tissue is controlled
and develops with the ultimate goal of informing the generation of new anti-obesity
therapeutics.
Adipose tissue is an important player in whole-body energy homeostasis. There
are several different types of adipose tissue that specialize in distinct functions (Rosen
and Spiegelman, 2014). White adipose tissue is an important energy-storing and
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endocrine organ that coordinates nutrient storage and intake. Studies from humans and
rodents have given us key insight into the importance of adipose tissue in organismal
physiology. Lack of adipose tissue in rodents leads to ectopic lipid accumulation in liver
and severe insulin resistance (Pajvani et al., 2005; Wang et al., 2013a). This phenotype
is conserved in patients with mutations in genes that cause lipodystrophy (Gandotra et al.,
2011; Kozusko et al., 2015; Lotta et al., 2017; Petersen et al., 2002; Rubio-Cabezas et al.,
2009). In addition to serving as an important energy storage organ, white adipose tissue
coordinates systemic nutrient availability in times of stress (Rosen and Spiegelman, 2014).
The ability of adipocytes to release stored energy in the form of fatty acids is required for
survival in acute stress situations including fasting and cold-exposure (Schreiber et al.,
2017). Furthermore, adipose tissue functions as an endocrine organ to regulate energy
intake. Identification of leptin as an adipocyte-secreted factor that controls energy intake
in the brain highlights the key role adipose tissue plays in coordinating systemic energy
balance (Friedman and Halaas, 1998).
Another type of adipose tissue has emerged as an important regulator of energy
expenditure as opposed to energy intake and storage. Thermogenic adipose tissue is
notable for its ability to burn large amounts of glucose and fatty acids to generate heat
through a process termed nonshivering thermogenesis (Cannon and Nedergaard, 2004).
Canonically, nonshivering thermogenesis is facilitated by expression of an inner
mitochondrial membrane protein, Uncoupling Protein 1 (UCP1), which, when activated,
uncouples the mitochondrial proton gradient from ATP synthesis. This action creates an
electrochemical driving force to oxidize large amounts of fuel in the mitochondria and the
inefficiency of these metabolic reactions generates heat (Cannon and Nedergaard, 2004).
UCP1-dependent thermogenic adipose tissue activity is an important source of heat
generation, in addition to shivering thermogenesis, and is required in certain inbred rodent
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lines for survival during cold-exposure (Cannon and Nedergaard, 2004; Ukropec et al.,
2006). Cold exposure increases sympathetic outflow from nerve terminals in thermogenic
adipose tissue resulting in the release of norepinephrine (NE). NE activates Protein Kinase
A-dependent processes downstream of the beta-adrenergic signaling system to facilitate
the maximal activity of UCP1 and the coordinated delivery of nutrients to the mitochondria
for oxidation (Cannon and Nedergaard, 2004). Recently there has been great interest in
identifying novel UCP1-independent, energy-burning pathways in adipocytes (Ukropec et
al., 2006). This has led to the discovery of two futile cycles including phospho-creatine
and calcium shunts active in thermogenic adipocytes (Ikeda et al., 2017; Kazak et al.,
2015, 2017, 2019). Notably, the evidence supporting the requirement for these two shunts
in preserving cold-tolerance in UCP1-replete mice appears weak (Ikeda et al., 2017;
Kazak et al., 2017, 2019).
Recognizing the potential for this adipose tissue to serve as a potential source of
energy expenditure, investigators sought to identify key molecules that are required for
and necessary to promote thermogenic competency. Utilizing genetic models in rodents,
many groups have described ectopic activation of key factors that control thermogenesis
in less thermogenic adipose depots is sufficient to suppress weight gain and associated
metabolic disease through increases in energy expenditure (Seale et al., 2011; Shao et
al., 2016; Stine et al., 2016). Notably during the course of these studies, many groups,
including our own have identified that while ectopic activation of thermogenesis is
sufficient to increase basal energy expenditure, key regulators of thermogenesis
(discussed below) are not required for basal energy expenditure, but rather for adrenergicstimulated energy expenditure (Emmett et al., 2017; Harms et al., 2014). This observation
has motivated the field to identify factors that are sufficient to promote thermogenic
competency in vivo.
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Perivascular Adipose Tissue as a Unique Thermogenic Adipose Depot
Adult humans have large amounts of thermogenic adipose tissue in the
supraclavicular region and surrounding large blood vessels (Cypess et al., 2013, 2015;
Huttunen et al., 1981). These UCP1+ positive adipocytes have also been described in the
mediastinum and carotid sheath of adult humans (Cheung et al., 2013b; Cypess et al.,
2013). Additionally, this thermogenic adipose tissue also increases uptake of glucose in
response to administration of beta-3 adrenergic stimulation in humans (Cypess et al.,
2015). Given the location of thermogenic adipocytes in close proximity to the vasculature,
great interest has been spurred in whether these adipocytes influence vascular physiology
and pathology. One key issue in the field is the ability to specifically target perivascular
adipose tissue (PVAT) while sparing other thermogenic adipose depots. The Chawla and
Tontonoz groups identified that PVAT becomes whitened in mice acclimated to
thermoneutrality and this is associated with increased atherogenesis (Tian et al., 2016).
Notably, this experimental paradigm is confounded, as mice display systemic changes in
circulating triglycerides and cholesterol following thermoneutral acclimation, which could
directly contribute to atherogenesis (Tian et al., 2016). Therefore, groups have sought to
use specific Cre drivers that label PVAT while sparing other adipose depots for
experimental manipulation. The Chen group identified that Tagln+ cells give rise to PVAT,
but not adipocytes in interscapular BAT or subcutaneous white adipose (Chang et al.,
2012). Notably, they deleted PVAT by breeding mice expressing Tagln-Cre in mice that
had a Pparg floxed allele. Generation of this PVAT-dystrophic mouse revealed that this
depot played a role in regulating adaptive thermogenic responses, only when interscapular
BAT was removed (Chang et al., 2012). They crossed these mice to an atherosclerosis
susceptible background (Apoe-/-) and demonstrated that PVAT was required for the
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atherosclerosis-suppressing phenotype of modest cold exposure (Chang et al., 2012).
Notably, they were unable to reveal a role for PVAT in regulating atherogenesis in room
temperature housed mice (Chang et al., 2012). This group also previously reported that
Pparg expression in smooth muscle cells is required for vascular tone, further complicating
the interpretation of these results (Chang et al., 2009). It remains to be determined whether
there exists anything unique about the role of the thermogenic program of PVAT in
regulating vascular physiology, and novel reagents are required to appropriately answer
these questions.
The observation that Tagln+ cells develop into the PVAT, but not other adipose
depots has spurred interest in defining the precise lineage of thermogenic PVAT (Chang
et al., 2012). Some groups suggest that mature smooth muscle cells differentiate into
perivascular adipocytes, while others suggest that precursor cells that express Tagln+
early during embryonic development become thermogenic PVAT (Chang et al., 2012; Ye
et al., 2019). Notably, some groups have described that descending thoracic PVAT
possesses more thermogenic properties than abdominal aorta; whether this is due to
different composition of the tissue or a progenitor-cell autonomous difference remains to
be determined (Tran et al., 2018). Other studies have sought to profile adventitial cells
using unbiased technologies, but have revealed little information on the developmental
trajectory governing thermogenic PVAT development (Gu et al., 2019; Pan et al., 2019).
Taken together, there exists an urgent need to understand the development of
thermogenic PVAT to facilitate the generation of reagents to answer pressing questions
about the physiologic importance of these thermogenic adipocytes surrounding large
blood vessels.

Thermogenic adipose tissue in humans
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Investigators have been tempted for many years by the prospect of activating an
endogenous system that facilitates coordinated energy burning as an obesity therapeutic,
but were dismayed by the apparent lack of thermogenic adipose tissue present in adult
humans. It has been known for many years from post-mortem studies that small babies
have large amounts of thermogenic, UCP1-expressing adipose tissue located in the
interscapular and supraclavicular regions (AHERNE and HULL, 1964; Heaton, 1972; Lidell
et al., 2013). Prior to 2009, it was thought that in adult humans, thermogenic adipose
tissue was only present in people exposed to chronic, extreme cold and patients with
pheochromocytomas that secrete large amounts of adrenergic-stimulating compounds
(Abdul Sater et al., 2020; Hadi et al., 2007; Huttunen et al., 1981; Puar et al., 2016). In
2009, three groups measured glucose uptake in vivo using FGD-PET-CT coupled with
histologic analysis to identify that human adults have sizeable amounts of thermogenic
adipose tissue (Cypess et al., 2009; van Marken Lichtenbelt et al., 2009; Virtanen et al.,
2009). These groups identified large amounts of thermogenic adipose tissue located in
the supraclavicular region, as well as surrounding large blood vessels (Cypess et al.,
2013). Further studies have suggested that thermogenic adipose tissue deeper within the
neck region is more thermogenic when compared to adipose tissue with a more
subcutaneous distribution, as assayed by morphology and expression of UCP1 (Cypess
et al., 2013). Subsequent studies have attempted to describe which of these human
thermogenic adipose depots are most similar to mouse thermogenic adipose depots;
however, these studies typically relied either on expression of specific markers in
differentiated adipocytes or analysis of tissues with heterogenous cell type compositions
(Shinoda et al., 2015; Wu et al., 2012). Taken together, the discovery of thermogenic
adipose tissue in humans revolutionized the field of adipocyte biology and catalyzed
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interest in studying whether thermogenic adipose tissue activation could serve as a viable
antiobesity target in humans.
Motivated by these initial studies, several groups have sought to activate and
recruit thermogenic adipose tissue using environmental and pharmacologic paradigms in
humans. Initially groups focused on whether they could augment endogenous BAT activity
with cold exposure, as assayed by glucose uptake in FDG-PET. Subsequent studies
attempted to determine if this intervention was sufficient to improve metabolic health.
Many studies from different groups across the globe have demonstrated cold-exposure
increases BAT activity in adult humans using a variety of acclimation protocols (Cypess
et al., 2012; van der Lans et al., 2013; Vosselman et al., 2012; Yoneshiro et al., 2011).
However, there exists some controversy as to which mechanism of pharmacologic
activation promotes thermogenic adipose tissue activation in humans. Some groups using
pan-adrenergic agonists including ephedrine have not been able to identify effects of
sympathetic activation on promoting thermogenesis (Cypess et al., 2012). Notably,
administration of a clinically available beta-3 adrenergic agonist, mirabegron, has been
shown to increase thermogenic adipose tissue in several publications highlighting the
potential for this specific agonist in controlling thermogenesis (Cypess et al., 2015).
Interestingly, some groups identified a relationship between cold-induced adaptive heat
generating and the season the study was performed, highlighting the complex interplay
between environmental factors influencing thermogenesis (Yoneshiro et al., 2016).
Following identification of a paradigm that increases thermogenesis in humans,
many groups sought to determine whether these interventions were sufficient to suppress
metabolic disease. One group identified that cold exposure increase thermogenic adipose
tissue activity and decreased body fat mass following a 6 week study (Yoneshiro et al.,
2013). Another group identified that systemic insulin sensitivity was increased as assayed
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by hyperinsulinemic-euglycemic clamp following a shorter, 10 day, cold exposure
treatment paradigm (Hanssen et al., 2015). A third group stratified individuals who had
and did not have BAT prior to the study and identified that cold exposure resulted in
improved insulin sensitivity only in the population of patients who had brown adipose
tissue (Chondronikola et al., 2014). Pharmacologic activation of beta-3 adrenergic
receptors was sufficient to increase basal metabolic rate and improve insulin sensitivity in
obese patients (Finlin et al., 2020; O’Mara et al., 2020). Notably, in one of the studies,
they were unable detect increases in thermogenic adipose tissue mass, but noted a
potential gene signature of subcutaneous adipose tissue remodeling that they
hypothesized could facilitate insulin sensitivity (Finlin et al., 2020). Taken together, human
and rodent studies have demonstrated that utilizing various pharmacologic and
environmental approaches to increase thermogenic adipose tissue mass confer beneficial
metabolic effects. These data have motivated our interest in studying the molecules that
control thermogenic adipose tissue activation and development as well as identifying the
cell types that develop into thermogenic adipocytes in vivo.
TRANSCRIPTIONAL CONTROL OF BROWN ADIPOCYTE DIFFERENTIATION AND
ACTIVATION
Understanding the factors that control thermogenic adipocyte differentiation and
function requires a fundamental understanding of how adipocyte differentiation is
regulated. Interestingly, many factors that were originally identified in screens as
regulators of adipogenesis were subsequently demonstrated to play important roles in
thermogenic adipocyte function. Technologic advances including the sequencing of the
genome and next-generation sequencing have been instrumental in facilitating the
discovery of molecules controlling adipocyte differentiation. Initial studies focusing on
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identifying the master regulators of adipogenesis used immortalized fibroblastic cell lines
that undergo robust adipogenic differentiation in the presence of a defined cocktail that
includes dexamethasone, IBMX, and indomethacin. During this process, these fibroblastic
cells undergo dramatic transcriptional changes on their trajectory to become adipocytes.
Investigators sought to study the factors important for regulating genes that increased
during adipogenesis as a mechanism to identify master regulators of adipogenesis. Initially
using the ap2 gene as a model for a gene whose expression is induced during
differentiation, the Lane group initially identified CCAAT/enhancer binding protein (C/EBP)
as an important regulator of ap2 enhancer expression (Christy et al., 1989; Herrera et al.,
1989). Further studies identified that C/ebp expression increased during the course of
differentiation and that C/ebp-alpha is required for adipogenesis (Herrera et al., 1989; Wu
et al., 1999a). However, C/EBP was previously identified as expressed in liver, and could
not be an adipocyte-specific regulator of differentiation. Therefore, these and other groups
hypothesized that there must exist an adipocyte-specific regulator of differentiation
(Graves et al., 1986).

Identification of a master regulator of adipogenesis
During the early 1990s, the Spiegelman and Lazar groups undertook
complementary studies that ultimately led to the identification of Peroxisome proliferatoractivated receptor (PPAR) gamma as an adipose-specific regulator of adipogenesis. The
Spiegelman group used an approach similar to the Lane group by identifying adipocytespecific enhancers and studying the factors that bound and activated transcription at those
enhancers (Graves et al., 1991, 1992). They identified an adipocyte-enriched factor,
ARF6, that bound to a specific DNA-sequence, known as a DR-1 motif, at an ap2
enhancer. They demonstrated that one factor known to bind DR-1 motifs, the Retinoid X
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Receptor Alpha (RXRa) was required for the activity of ARF6 (Tontonoz et al., 1994a).
They hypothesized that an adipocyte-expressed PPAR served as a heterodimer for RXRa
and identified PPARg as an adipocyte enriched PPAR whose expression was increased
during differentiation (Tontonoz et al., 1994a). Notably in orthogonal biochemical
approaches using brown adipocyte nuclei, the Speigelman lab identified that ARF6 was
composed of a PPARg/RXRa complex (Tontonoz et al., 1994b). In contrast to the
enhancer-focused approach of the Spiegelman lab, the Lazar group focused on the
biochemical requirements of adipogenesis to identify novel regulators of differentiation.
Motivated by the observation that bezafibrate, an agonist for PPARs, improved the
differentiation of preadipocytes into adipocytes and the knowledge that PPARs had been
implicated in controlling lipid handing, they demonstrated that lipid-containing serum was
required for 3T3L-1 adipocytes to undergo adipogenesis (Brandes et al., 1987; Chawla
and Lazar, 1994). Interestingly, they could pharmacologically rescue cellular morphology
associated with this nutrient deficiency with PPAR agonists and subsequently
demonstrated that Pparg is the adipocyte-enriched PPAR whose levels increase during
differentiation (Chawla and Lazar, 1994; Chawla et al., 1994).
Following the identification of Pparg, the Spiegelman group identified that ectopic
expression of Pparg and treatment with a PPARg agonist, rosiglitazone, is sufficient to
facilitate adipocyte differentiation in non-adipogenic NIH3T3 fibroblasts (Tontonoz et al.,
1994c). Furthermore, coexpression of Pparg and C/ebpa were sufficient to promote
adipogenesis in these non-adipogenic fibroblasts in the absence of rosiglitazone
(Tontonoz et al., 1994c). Subsequent studies from the Farmer and Spiegelman groups
sought to determine the relationship between C/EBPs and PPARg. The Farmer group
identified that increasing C/ebpb levels in non-adipogenic fibroblasts caused increase
expression of Pparg (Wu et al., 1995). Later studies identified that while C/EBPa cannot
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induce adipogenesis in Pparg null cells, Pparg expression is sufficient to rescue the
adipogenic-block in C/ebpa mutant cells (Rosen et al., 2002; Wu et al., 1999a). This
relationship between PPARg and C/EBPs has been further elaborated by studying the
impact of glucocorticoid signaling in controlling Pparg expression during the early stages
of differentiation (Wu et al., 1996). Notably, many of these observations have been
validated and expanded upon by groups using genome-wide approaches to study
adipogenesis. The Mandrup group profiled enhancers and binding of key adipogenic
transcription factors in developing adipocytes and identified distinct timing of the
glucocorticoid receptor (GR), C/EBPb, and PPARg binding during differentiation with GR
and C/EBPb binding occurring earlier (within hours) during differentiation and PPARg
binding later (Siersbaek et al., 2011). Further in vivo studies by the Lazar group
determined that Pparg expression in adipocytes is required for adipose tissue
maintenance and glucose homeostasis (Wang et al., 2013a). Mice lacking Pparg in
adipocytes develop a lipodystrophic phenotype along with lipid accumulation in their liver.
Taken together, these studies have highlighted the essential role of PPARg as a master
regulator of adipogenesis and adipose tissue maintenance.
Further interest in the biology of PPARg was stimulated by the discovery that the
class of antidiabetic drugs with insulin sensitizing effects, thiazolidinediones (TZDs), were
ligands for PPARg (Lehmann et al., 1995). This class of drugs has profound effects on
improving systemic glucose handling and insulin signaling in diabetic and non-diabetic
patients; however, its side effect profile has limited its use clinically (Nolan et al., 1994).
Determining how agonism of PPARg through TZDs improves insulin sensitivity has been
an area of immense study. Initial studies identified that TZD treatment increased visceral
white adipose tissue oxygen consumption and facilitated adipose tissue remodeling
(Wilson-Fritch et al., 2004). Other studies have identified strain-specific effects of TZDs in
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facilitating the acquisition of an energy burning phenotype in subcutaneous adipose tissue
by increasing expression of Ucp1 (Soccio et al., 2017).

Factors controlling adrenergic-stimulated gene expression in brown adipocytes
Spurred by the promise of activating brown adipocytes in vivo to suppress
metabolic disease, many groups have sought to determine what factors are required for
and sufficient to promote the brown adipocyte thermogenic program. The thermogenic
program refers to the competency for an adipocyte to perform sympathetic-stimulated
uncoupled respiration. Required components of this program include sufficient numbers
of mitochondria, the metabolic machinery to import and oxidize large amounts of glucose
and fatty acid, the signaling components required to facilitate responsiveness to
adrenergic stimulation, and finally the robust expression of UCP1, which drives the entire
thermogenic pathway. Expression of thermogenic genes can be regulated during
differentiation of fibroblastic progenitors or adrenergic stimulation of mature adipocytes
(Figure 1.1). Groups prioritized several strategies to determine what factors could drive
this energy-burning program, but the most successful the first took advantage of the
relative similarities of thermogenic and non-thermogenic adipocytes to identify brownadipocyte specific transcriptional regulators that promote thermogenesis.
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Figure 1.1. Schematic of thermogenic adipocyte differentiation and activation. A)
Schematic of thermogenic adipocyte differentiation and maximal activation. B) Schematic
of Ucp1 locus in brown preadipocytes, brown adipocytes, and maximally activated brown
adipocytes. C) Selected factors that control the transcriptional response of differentiating
preadipocytes and stimulated adipocytes.

Inspired by the dramatic effect of PPARg in controlling adipogenesis, the
Spiegelman group sought to identify factors that interacted with PPARg to regulate its
activity in brown adipocytes using a yeast two-hybrid system (Puigserver et al., 1998).
They sought to identify specific regulators of PPARg in brown fat by performing their
screen in brown adipocytes and prioritized hits based on enriched expression in brown
relative to white adipocytes. They identified Pparg Coactivator 1 alpha (PGC1a), a factor
that interacts with PPARg to promote thermogenic gene expression (Puigserver et al.,
1998). Notably, transcription of this factor was regulated by cold exposure and adrenergic
signaling in BAT and expression of Pgc1a in white adipocytes was sufficient to increase
mitochondrial content, a hallmark of thermogenic cells (Puigserver et al., 1998; Wu et al.,
1999b). Further studies identified that PGC1a expression was also sufficient to promote
expression of Ucp1 in non-thermogenic fat cells (Puigserver et al., 1998; Wu et al., 1999b).
Given PGC1a was a master regulator of mitochondrial biogenesis in thermogenic fat cells,
other studies sought to determine whether this factor was important mitochondria;
biogenesis for other cell types with high levels of mitochondria, such as skeletal and
cardiac muscle. Complementary studies by the Spiegelman and Kelly groups identified
that many of the mitochondria-generating effects of PGC1a were tissue-type-independent
by establishing PGC1a was important for promoting mitochondrial content in skeletal and
cardiac muscle cells. (Lehman et al., 2000; Wu et al., 1999b).
Given the transcriptional regulation of Pgc1a by cold and adrenergic signaling,
many investigators sought to determine how specifically PGC1a promotes Ucp1
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expression during adrenergic stimulation. Initial studies from the Kozak group identified
an enhancer element at the Ucp1 locus that was important for basal and adrenergicstimulated expression contained two cyclic AMP-response elements that were required
for the adrenergic-stimulated expression of Ucp1 (Kozak et al., 1994). Cyclic AMP
Response element binding protein (CREB) binds cyclic AMP-response elements to
promote gene transcription and was shown to cooperate with PGC1a in the liver to support
the metabolic response to fasting (Herzig et al., 2001). Seminal work from the Collins
group identified that in brown adipocytes adrenergic signaling increased cAMP levels and
activated p38 MAPK (Cao et al., 2001). p38 MAPK activity in brown adipocytes promotes
expression of Pgc1a as well as the transcriptional activities of PGC1a and Activating
Transcription Factor 2 (ATF-2) (Cao et al., 2004). Taken together, these data support the
model that adrenergic signaling increases the transcription of thermogenic genes,
including Ucp1, through the coordinate activation of p38 MAPK and induction of CREB,
PGC1a, and ATF-2 activities in brown adipocytes.
Further analysis of the genetic requirement for Pgc1a and the homologous, Pparg
coactivator 1b (Pgc1b), in thermogenic adipocytes revealed overlapping roles for these
factors in basal and adrenergic-stimulated thermogenic gene expression (Lin et al., 2002;
Uldry et al., 2006). The Spiegelman group identified that Pgc1a expression is required
specifically for adrenergic-stimulated thermogenic gene expression (Uldry et al., 2006).
Codeletion of Pgc1a and Pgc1b led to a defect in thermogenic gene expression following
adipocyte differentiation, and after administration of adrenergic agonists (Uldry et al.,
2006). This compensation by two PGC1 factors has made it difficult to identify an in vivo
requirement for PGC proteins in mediating adaptive thermogenesis. Notably, the
Spiegelman group identified that expression of Pgc1a in adipocytes is required to maintain
insulin sensitivity in vivo (Kleiner et al., 2012). While Pgc1a expression was dispensable
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for BAT thermogenic gene expression, examination of subcutaneous white fat revealed a
subtle thermogenic defect. In contrast, the Lazar group identified that expression of Hdac3
is required to maintain thermogenic gene expression in BAT through PGC1a (Emmett et
al., 2017). Mechanistically, they identified that HDAC3 deacetylates PGC1a to promote its
activity and control adaptive thermogenesis (Emmett et al., 2017).
Whether PGC1a cooperated exclusively with PPARg was unexplored until the
Kelly group performed a yeast two-hybrid screen for PGC1 interactors expressed in
cardiac tissue (Huss et al., 2002). They identified two members of a then understudied
class of nuclear receptors, Estrogen Related Receptor (ERR) alpha and gamma, that
cooperated with PGC1a to promote expression of fatty acid oxidation genes (Huss et al.,
2002). Initially identified on the basis of sequence similarity to other nuclear receptors, the
ERRs are a family of nuclear receptors whose role in regulating metabolic processes was
unknown prior to this study (Giguère et al., 1988). Further studies from the Kralli group
identified that PGC1a increased expression of Esrra, establishing a feedforward regulatory
loop controlling mitochondrial content (Schreiber et al., 2003, 2004). Mechanistically, it is
accepted that many of the functions of ERRa and ERRg are overlapping, with CHIP data
from the Giguere lab in the heart highlighting the shared binding motif for the two factors
(Dufour et al., 2007).

Studies on cultured brown adipocytes identified that Esrra

expression was required only for adrenergic-stimulated thermogenic gene expression
(Gantner et al., 2016). Notably, these studies contrast in vivo studies in whole-body Esrra
mutant mice that demonstrated Esrra expression is required for basal mitochondrial
content and adaptive thermogenesis (Villena et al., 2007). This observation has been
supported by in vivo models of adipocyte-specific loss of Esrra and Esrrg. Mice lacking
Esrrg have defective in vivo thermogenesis and basal BAT thermogenic gene expression
(Ahmadian et al., 2018). Codeletion of Esrra and Esrrg in adipocytes in mice leads to
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dramatic whitening of BAT, with little Ucp1 expression and low mitochondrial content
basally (Brown et al., 2018). Notably, these mice are unable to augment adrenergicstimulated respiration following chronic administration of a beta-3 adrenergic receptor
agonist (Brown et al., 2018). Taken together, these experiments highlight the importance
of ERRs in promoting mitochondrial content and UCP1 expression in thermogenic
adipocytes basally and following adrenergic stimulation.
In addition to ERRs, other factors have been demonstrated as important regulators
of PGC1a activity, including Interferon Regulatory Factor 4 (IRF4). The Rosen group
profiled accessible DNA regions near adipocyte-specific genes and identified enrichment
of an IRF motif (Eguchi et al., 2008). They prioritized study of IRF4, whose expression
was enriched in adipocytes when compared to stromal cells (Eguchi et al., 2011).
Interestingly, Irf4 mutant mice gained more weight on high fat diet when compared to
control mice. Loss of Irf4 in adipocytes led to whitening of interscapular BAT and cold
intolerance. Examination of the physiologic regulators of Irf4 expression revealed that Irf4
expression increases with cold acclimation and beta-agonist treatment, highlighting it may
play a role in regulating thermogenic adipose tissue activity (Kong et al., 2014). These
observations motivated the Rosen group to design a Cre driver that was specifically active
in thermogenic adipocytes, Ucp1-Cre (Kong et al., 2014). Using this reagent, the Rosen
group identified that brown-adipocyte expression of Irf4 is required for cold-tolerance and
in vivo thermogenesis (Kong et al., 2014). Furthermore, increasing expression of Irf4 in
BAT is sufficient to increase thermogenic gene expression, energy expenditure, and
suppress weight gain on a high fat diet (Kong et al., 2014). Mechanistically, they identified
that IRF4 directly interacts with PGC1a to promote thermogenic gene transcription (Kong
et al., 2014). These experiments identified an important role for IRF4 in controlling PGC1a
activity to promote thermogenic gene expression and in vivo thermogenesis.
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Factors controlling the differentiation of thermogenic adipocytes
PGC proteins, ERR proteins and IRF4 play outsized roles in the transcriptional
response of mature thermogenic adipocytes to adrenergic-stimulation when compared to
transcriptional network controlling the de novo differentiation of thermogenic adipocytes.
In later studies, Spiegelman group sought to identify factors that controlled the
differentiation of fibroblastic progenitors into mature thermogenic adipocytes. Screening
transcription factors that are enriched in brown versus white fat cells led to the
identification of PR domain containing 16 (PRDM16) as a potent regulator of the
development and adrenergic-activation of the brown fat program (Seale et al., 2007). In
their initial report, Seale and colleagues identified that PRDM16 was required for basal
and sympathetic-stimulated uncoupled respiration in brown adipocytes (Seale et al.,
2007). Mechanistically, they identified that PRDM16 bound and activated PGC1a to
promote thermogenic gene transcription (Seale et al., 2007). Interestingly, in contrast to
other regulators of thermogenesis, PRDM16 functioned essentially as a coactivator; its
DNA binding domain was dispensable for its control of the thermogenic program (Seale
et al., 2007). Future studies identified that ectopic Prdm16 expression was sufficient to
promote brown adipogenesis in non-adipogenic C2C12 myoblasts when exposed to
adipogenic cocktail (Seale et al., 2008). This experiment coupled with the observation that
PRDM16 directly bound PPARg and coactivated PPARg highlighted the important role of
PRDM16 as a master regulator of the thermogenic adipocyte differentiation. Interestingly,
the Kajimura group identified that PRDM16 mediated the thermogenic-promoting actions
of TZDs on subcutaneous white adipocytes (Ohno et al., 2012). They identified that TZDs
stabilize PRDM16 protein to facilitate thermogenic gene transcription during adipocyte
differentiation (Ohno et al., 2012).
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Examination of how PRDM16 controlled adipogenesis in C2C12 myoblasts
revealed fundamental biology of how this factor controls early adipogenic fate decisions.
The observation that Pparg expression in C2C12s is very low suggested that cooperativity
with PPARg was not the only mechanism by which PRDM16 functioned to promote
adipogenesis (Kajimura et al., 2009). Kajimura and colleagues in the Spiegelman group
profiled binding partners of PRDM16 and identified that PRDM16 bound C/EBP-beta
(Kajimura et al., 2009). Expression of C/EBPbeta in nonadipogenic fibroblasts is sufficient
to promote Pparg expression and sensitization to adipogenic cocktail (Wu et al., 1995).
Taken together, these experiments identify an important role for PRDM16 in controlling
the early, intermediate, and terminal phases of thermogenic adipogenesis through
interactions with C/EBPb, PPARG, and PGC1a.
Subsequent in vivo studies identified that ectopic expression of Prdm16 is
sufficient to drive the thermogenic gene program in subcutaneous white adipose tissue
(Seale et al., 2011). This genetic manipulation increased energy expenditure and
suppressed weight gain in mice fed a high fat diet. Surprisingly, Prdm16 expression in the
brown adipose lineage and adipocytes is dispensable for the thermogenic phenotype of
BAT in vivo (Cohen et al., 2014; Harms et al., 2014). The Seale group identified that
expression of a closely related factor PRDM3 compensated for the loss of Prdm16 in the
brown-adipocyte lineage (Harms et al., 2014). Codeletion of Prdm16 and Prdm3 led to
dramatic whitening of BAT (Harms et al., 2014). These experiments highlight the functional
redundancy of PRDM proteins in controlling BAT thermogenesis. In contrast, Prdm16
expression is required for the expression of thermogenic genes in subcutaneous white
adipose tissue (Cohen et al., 2014). The importance of this gene program in subcutaneous
white fat was revealed when it was identified that mice lacking Prdm16 in adipocytes
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display increased weight gain on high fat diet with associated insulin insensitivity (Cohen
et al., 2014).
Given the importance of PRDM16 in controlling the thermogenic gene program in
brown adipocytes, many groups sought to examine whether factors that controlled
thermogenesis did so by modulating PRDM16 activity. The Sul group identified ZFP516
in a screen of transcription factors that promoted the expression of Ucp1 (Dempersmier
et al., 2015). Zfp516 expression was elevated in BAT versus WAT and was required for
BAT thermogenic gene expression in vivo (Dempersmier et al., 2015). This group
suggested that ZFP516 bound PRDM16 to control thermogenic gene transcription
(Dempersmier et al., 2015). In complementary studies, the Tontonoz group identified TLE3
as a potent suppressor of thermogenesis (Villanueva et al., 2013). Initially studied as a
regulator of adipogenesis, Tle3 expression was enriched in white fat cells versus brown
fat cells and ectopic expression was sufficient to decrease thermogenic gene expression
in brown fat cells (Villanueva et al., 2011, 2013). This group identified that TLE3
suppressed thermogenic gene expression by competing with PRDM16 for PPARG binding
(Villanueva et al., 2013). These studies suggest modulating PRDM16 activity is an
important node of regulation for the brown fat gene program.
Future studies sought to determine what factors control the expression of PRDM16
in the brown adipose lineage. The Seale lab identified one such factor, Early B Cell Factor
2 (EBF2), when studying how PPARg binds to its BAT-specific sites (Rajakumari et al.,
2013). Rajakumari and colleagues performed chromatin immunoprecipitation (CHIP)
followed by next generation sequencing of PPARg in BAT and WAT and identified an EBF
motif enriched at PPARg binding sites in BAT when compared to WAT. Notably, there are
three adipocyte-expressed EBF transcription factors, with EBF2 displaying enriched
expression in BAT when compared to iWAT (Rajakumari et al., 2013). CHIP studies and
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transcription factor reporter assays identified that EBF2 cooperated with PPARG to
promote transcription at an enhancer located near Prdm16 (Rajakumari et al., 2013).
EBF2 binding to this enhancer was detected prior to PPARG binding, suggesting that
EBF2 functioned before PPARG in the brown adipogenic cascade (Rajakumari et al.,
2013). Brown adipocytes lacking Ebf2 displayed defective thermogenic gene expression
and sympathetic-stimulated respiration (Rajakumari et al., 2013). Interestingly, EBF2
expression was also sufficient to drive brown adipogenesis when ectopically expressed in
C2C12 myoblasts, similar to PRDM16. Notably, ectopic expression of EBF2 was sufficient
to promote adoption of a thermogenic phenotype in subcutaneous white adipose tissue
(Stine et al., 2016). This increase in thermogenic character led to resistance to diet
induced obesity and improved glucose homeostasis (Stine et al., 2016). Whether EBF2
played important roles in mature adipocyte thermogenic gene transcription or adaptive
thermogenesis in vivo remained an outstanding question.
Following these studies, it was unknown how EBF2 controlled thermogenic gene
transcription during brown adipogenesis. Shapira and colleagues identified that EBF2
regulates chromatin occupancy at brown fat specific genes through interacting with the
BAF chromatin remodeling complex (Shapira et al., 2017). Further studies highlighted that
EBF2 controlled the expression of a brown-fat specific member of the BAF chromatin
remodeling complex, Dpf3, through an intronic enhancer (Shapira et al., 2017). Dpf3
expression in brown adipocytes was required for basal and sympathetic-stimulated
thermogenic gene expression and energy expenditure (Shapira et al., 2017). Notably,
these studies complemented studies from the Grosschedl group which identified that a
closely related EBF family member, EBF1, was able to bind closed chromatin and remodel
nucleosomes during B Cell differentiation (Boller et al., 2016). Interestingly, the Rosen
group had described a previous role for EBF1 in controlling adipogenesis in white
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adipocytes. Using the immortalized 3T3-L1 adipogenesis model, the Rosen group and
others demonstrated that Ebf1 is required for adipogenesis and ectopic Ebf1 expression
is sufficient to promote adipogenesis in non-adipogenic fibroblasts (Akerblad et al., 2002;
Jimenez et al., 2007). Future studies using CHIP and high-throughput transcriptomics
suggested a role for EBF1 in regulating inflammatory gene expression; however, whether
these effects were directly due to EBF1 activity or a general adipogenic defect remain to
be determined (Griffin et al., 2013).
During the studies that established a role for EBF activity in brown adipogenesis,
parallel studies initiated by Gupta and colleagues identified ZFP423 as a factor that
controlled adipogenesis and thermogenic competency (Gupta et al., 2010; Shao et al.,
2016). Gupta and colleagues screened factors that were enriched in adipogenic subcloned
3T3 fibroblasts and identified ZFP423 as a transcription factor that controlled Pparg levels
to promote adipogenesis in fibroblasts (Gupta et al., 2010). Interestingly, deletion of
Zfp423 in adipose tissue of adult mice led to dramatic acquisition of a thermogenic
phenotype in vivo (Shao et al., 2016). Previously, the Reed group had identified ZFP423
as protein that interacted with EBF1 in the nervous system (Tsai and Reed, 1997).
ZFP423 also interacts with EBF2 to suppress its activity in adipocytes suggesting this
factor functions to suppress thermogenic gene expression through its interaction with
EBF2 (Shao et al., 2016). Mice lacking Zfp423 in adipocytes when fed a high fat diet
gained less weight and had improved glucose tolerance when compared to wild-type mice
(Shao et al., 2016). Notably, deletion of Zfp423 alone in adipocytes was not sufficient to
suppress weight gain in already-obese mice (Shao et al., 2016). Obese mice lacking
Zfp423 in adipose tissue required adrenergic stimulation to lose more weight when
compared to wild-type controls (Shao et al., 2016). The Gupta group also identified that
ambient temperature regulated Zfp423 expression in BAT and identified that ZFP423
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played an important role in the transcriptional response of adipose tissue in mice housed
at thermoneutrality following cold exposure (rewarming) (Roh et al., 2018; Shao et al.,
2016). These studies established ZFP423 as one of the first transcriptional regulators that
linked developmental and adaptive thermogenic gene programs in developing and mature
brown adipocytes. Future studies are required to identify more factors that control both
developmental and adaptive thermogenic gene programs and the ways in which these
pathways interact to promote thermogenic competency.
DEVELOPMENT

OF

THERMOGENIC

ADIPOSE

TISSUE

DURING

EMBRYOGENESIS AND ADULTHOOD

A key requirement for precisely activating thermogenic adipose tissue mass or
activity in vivo requires knowledge of what cell types should be targeted. Understanding
how brown adipocytes develop under normal conditions could provide important insights
that facilitate thermogenesis in vivo. Thermogenic adipocytes develop in two defined
periods in mice: during embryonic development in the interscapular region and in adult
mice in response to environmental stresses such as cold exposure or adrenergic signaling
(Wang and Seale, 2016). Understanding the cells that give rise to thermogenic adipocytes
in vivo would allow the prospective isolation of these cells for autologous transplantation
and appropriate drug targeting with pharmacologic agents (Tseng et al., 2010). While it
was hypothesized that all thermogenic adipocytes developed from the same
developmental lineage, the Kozak group examined genetic differences among inbred mice
to suggest that the factors that control the development of adult thermogenic adipocytes
in white adipose depots (beige adipocytes) are distinct from those controlling
developmental specification of thermogenic adipocytes in homogenous brown fat depots
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(interscapular BAT) (Guerra et al., 1998). An elegant experiment identified that stromal
cells are stably wired to adopt the characteristics of adipocytes of the depot from which
they were isolated (Klaus et al., 1995) (Figure 1.2). Put another way, preadipocytes
isolated from brown adipose tissue became thermogenic adipocytes in vitro while,
preadipocytes isolated from white adipose tissue differentiated into white adipocytes
under the same culture conditions (Klaus et al., 1995). Notably, our lab and others have
sought to identify the precise identity of these thermogenic adipocyte progenitors, and
what transcriptional regulators differentiate these progenitors from cells destined to adopt
an energy-storing phenotype.
Development of thermogenic adipocytes during embryogenesis
Human babies and newborn mice have large amounts of interscapular brown
adipose tissue that develops during embryogenesis (AHERNE and HULL, 1964; Lidell et
al., 2013). Investigators have sought to determine the factors that control this
differentiation process and define the cell types along this developmental trajectory. The
prevailing hypothesis is that interscapular brown adipose tissue develops from a
mesodermal lineage around embryonic day 15.5 (E15.5) (Wang and Seale, 2016). Studies
from Seale and colleagues identified that brown adipocytes develop from a shared lineage
with skeletal muscle by analyzing mice expressing Cre-recombinase under control of Myf5
regulatory elements (Seale et al., 2008). Cells labeled with Myf5-Cre give rise to skeletal
muscle and interscapular brown adipocytes, but not white adipocytes, or thermogenic
adipocytes that develop in white adipose depots in response to adrenergic stimulation
(Seale et al., 2008). This observation catalyzed great interest in identifying whether brown
adipocytes develop from the same embryonic precursor for muscle or whether a pool of
pre-committed precursors share expression of Myf5. Many groups using constitutive Cre
drivers that trace to various mesodermal structures including Pax7-Cre, Meox1-Cre, and
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Pax3-Cre to determine that brown adipocytes develop from a mesodermal origin
(Sanchez-Gurmaches and Guertin, 2014; Sebo et al., 2018).
One key limitation to these experiments was the use of constitutive Cre drivers,
which do not provide information on the temporal nature of when labeled cells are
specified to become brown adipocytes. Two studies using tamoxifen-inducible CreER
driven by En1 and Pax7 regulatory elements identified that a population of cells residing
within the dermomyotome at embryonic day 10.5 are specified to become brown
adipocytes, skeletal muscle, and dermis (Atit et al., 2006; Lepper and Fan, 2010). Notably,
Pax7+ cells give rise to brown adipocytes until E11.5 and subsequently do not trace to
brown adipocytes, highlighting that a yet to be identified Pax7- adipogenic precursor cell
must exist between E12.5 and E15.5 (Lepper and Fan, 2010). These studies motivated
researchers to define the identity of the previously hypothesized Pax7- adipogenic
precursor cell which would may provide insight into how the thermogenic adipose lineage
is distinct from the skeletal muscle lineage. Wang, et. al. profiled fibroblastic cells in the
E14.5 embryo in the brown adipocyte lineage (Myf5-Cre-descendent) to identify factors
that controlled this preadipocyte phenotype (Wang et al., 2014). They identified Ebf2
expression as enriched in these Myf5-Cre descent fibroblasts when compared to
fibroblasts descendent from a Myf5-Cre- lineage (Wang et al., 2014). Using mice
expressing Gfp from the Ebf2 locus, Wang and colleagues were able to identify Ebf2+
fibroblastic cells were specified towards a thermogenic adipocyte phenotype and Ebf2fibroblastic cells towards a white adipocyte phenotype ex vivo (Wang et al., 2014). These
studies highlighted that EBF2 controlled the thermogenic as opposed to adipogenic
phenotype of fibroblastic cells. Whether these Pdgfra/Ebf2+ cells develop directly from
En1/Pax7+ progenitors or there is an intermediate cell state along this trajectory remains
an area of outstanding studies.

24

Further studies sought to identify the factors that played a role in regulating this
hypothesized muscle versus adipocyte fate choice in vivo. Identification of factors such as
PRDM16 and EBF2 which were sufficient to reprogram non-adipogenic C2C12 myoblasts
into brown adipocytes following exposure to adipogenic cocktail highlighted the important
role these factors play in thermogenic adipocyte development (Kajimura et al., 2009;
Rajakumari et al., 2013; Seale et al., 2008). Interestingly, in vivo loss of these factors
causes replacement of the BAT with whitened adipose tissue as opposed to muscle
(Harms et al., 2014; Rajakumari et al., 2013). These studies suggested that EBF2 and
PRDM16 control a thermogenic as opposed to adipogenic phenotype in vivo. In parallel
studies, investigators determined loss of insulin signaling and PPARg in brown adipocytes
and all adipocytes respectively leads to accumulation of fibrotic cells as opposed to
skeletal muscle (Lynes et al., 2015; Wang et al., 2013a). These results demonstrate that
loss of adipogenic signals are not sufficient to promote ectopic muscle development in
vivo.
Tseng and colleagues complemented these studies identifying the transcriptional
regulators of brown adipocyte differentiation by interrogating the signaling pathways that
drive thermogenic adipocyte commitment. Tseng and colleagues assayed the ability of
bone morphogenic proteins (BMPs) to promote brown adipocyte differentiation and
identified BMP7 as a potent driver of thermogenic adipogenesis (Tseng et al., 2008). They
were able to determine that BMP7 promoted thermogenic, as opposed to, adipogenic
gene expression through activation of p38 MAPK. Interestingly, pretreatment of
mesenchymal cells with BMP7 led to induction of C/ebpd and subsequent sensitization to
adipogenic cocktail. Similarly, to EBF2 and PRDM16, loss of Bmp7 in vivo led to dramatic
whitening of interscapular BAT. Notably, deletion of the receptor through which BMP7 can
signal, Bmpr1a, led to less BAT mass but the BAT that was present was as brown as BAT
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isolated from control mice (Tseng et al., 2008). These two in vivo models suggest that
BMP7 has roles in promoting adipogenesis that can be compensated for by other BMPs,
and that loss of signaling through BMPR1a can be compensated for by other BMP
receptors in some cells. Other groups have identified that transcription of BMP7 in brown
preadipocytes is important for their ability to make brown fat cells in vivo (Park et al., 2013).
Taken together, these studies have identified some of the factors and signaling molecules
that control embryonic BAT differentiation. It remains to be determined if there is a bipotent
progenitor that can give rise to muscle and brown adipose and what the precise identify
of potential intermediate cell types this mesodermal progenitor takes to become a
thermogenic adipocyte.

Development of thermogenic adipocytes during adulthood
Thermogenic adipocytes can develop in adult mice and humans to augment
energy expenditure and nonshivering thermogenesis in response to environmental stimuli
such as cold exposure (Cypess et al., 2015; Yoneshiro et al., 2013). Notably, these
adipocytes tend to develop in depots that normally have large amounts of white
adipocytes, in contrast to the homogenous interscapular brown adipose tissue, These
adipocytes, referred to as beige adipocytes, have similar transcriptomes when compared
to interscapular brown adipocytes, and have the capacity to increase energy expenditure
when stimulated with adrenergic agonists (Roh et al., 2018; Wu et al., 2012). The Wolfram
group identified that the cold-induced thermogenic phenotype of beige adipocytes is
plastic, with adipocytes in previously cold-exposed mice losing expression of UCP1
following removal from cold (Rosenwald et al., 2013). Interestingly, they identified that
these same previously Ucp1+ adipocytes reactivated expression of thermogenic genes
following another round of cold exposure (Rosenwald et al., 2013).
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Much effort has been dedicated to determining whether thermogenic adipocytes
that develop in white adipose depots come from transdifferentiation of white adipocytes or
de novo differentiation of stromal progenitor cells (Figure 1.2). Technical limitations have
limited the ability to determine what proportion of UCP1+ adipocytes develop from
preexisting or new adipocytes. One complicating factor in studies using genetic lineage
tracing in adipose tissue is the use of the selective-estrogen receptor modulator,
tamoxifen, which facilitates the temporal activity of Cre recombinase. Studies from the
Scherrer group suggested that classic-tamoxifen based lineage tracing approaches using
tamoxifen should be performed with caution, as tamoxifen administration results in the
death of adipocytes, predominantly in the visceral adipose tissue which would confound
experiments quantifying adipocyte turnover (Ye et al., 2015). Furthermore, tamoxifen
levels in adipose tissue remain detectable for an extended period of time, complicating
what defines an appropriate chase period (Ye et al., 2015). Therefore, if an investigator
were to use tamoxifen label all adipocytes with Adipoq-CreER and not wait a sufficient
amount of time to chase, all unlabeled fibroblastic cells that developed into UCP1+
adipocytes would be exposed to tamoxifen and inappropriately label as if they were
preexisting. This was the case in a study by Granneman and colleagues which identified
that all UCP1+ beige adipocytes developed from preexisting Adipoq-CreER labeled cells
(Lee et al., 2015). Notably, this group utilized Pdgfra-CreER to prospectively label
fibroblastic cells and demonstrated that UCP1+ cells that develop upon environmental
stimulation in iBAT develop from de novo fibroblasts (Lee et al., 2015). Our group used
this strategy in iWAT to identify de novo adipogenesis from fibroblastic cells contributes to
beige adipogenesis in the context of cold exposure (Wang et al., 2019). Due to this
concern over tamoxifen effects, the Scherrer and Gupta groups have utilized a
doxycycline-inducible approach to label mature adipocytes in a temporal specific manner
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(Wang et al., 2013b). Using this strategy, they have identified many, but not all,
thermogenic adipocytes develop from cells other than adipocytes in the context of cold
exposure in previously room temperature acclimated mice (Wang et al., 2013b). Notably,
the proportion of beige adipocytes developing from de novo differentiation increases in
mice housed at thermoneutrality since birth highlighting the important role for ambient
temperature in regulating beige adipogenesis (Shao et al., 2019). Therefore, we can
conclude that beige adipocytes develop from a shared lineage, with some differentiating
from a pre-existing white adipocyte and others from dedicated progenitors.

Figure 1.2. Schematic of thermogenic adipocyte differentiation upon cold exposure.
Defining the progenitor cells that give rise to thermogenic adipocytes in adult mice
in vivo has remained an outstanding question for the last decade. There exists great
controversy as to what these cells are and the marks that define them. Investigators have
clustered in two broad camps: one suggests that these cells develop from smooth muscle
or perivascular cells marked by expression of Myh11, Pdgfrb, and/or Acta2; the other
hypothesizes that these cells develop from fibroblastic cells that are marked by Pdgfra
and may have low or ectopic expression of smooth muscle markers. Initial studies from
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the Graff lab sought to identify how new adipocytes are generated in vivo by using a
knockin-knockout Pparg allele which replaces expression of one Pparg allele with a
doxycycline-responsive-tTa (Tang et al., 2008). They utilized this model coupled with a
novel stromal-vascular isolation protocol to identify Pparg-expressing cells reside near the
vasculature and have the capacity to develop into adipocytes ex vivo. Notably, the Pparg+
cells coexpressed ACTA2 and PDGFRb (Tang et al., 2008). Further studies from this
group identified that these Acta2+ cells have the capacity to generate thermogenic
adipocytes in vivo using mice expressing CreER under the regulatory elements of Acta2
(Berry et al., 2016; Jiang et al., 2014).
In parallel studies, the Gupta group identified that cells that express Zfp423, a
master regulator of adipogenesis, also express Pdgfrb, a pericyte marker (Gupta et al.,
2012). They performed lineage tracing in mice to identify that Pdgfrb+ cells become
thermogenic adipocytes following extended cold challenge (Vishvanath et al., 2016).
Additionally, cells labeled with another smooth muscle-expressed gene, Tagln, became
adipocytes following cold exposure (Berry et al., 2016). Interestingly, this group highlighted
that adipocytes that develop from different time periods come from distinct progenitor
compartments, with the Acta2+ cells developing into adipocytes during adulthood, while
embryonic-specified adipocytes are Acta2- (Jiang et al., 2014). The Spiegelman group
used an orthogonal approach, profiling translating ribosomes from Ucp1+ cells in vivo to
identify beige adipocytes display increased translation of genes expressed in smooth
muscle cells (Long et al., 2014).

They utilized mice expressing CreER under the

regulatory elements of Myh11 to identify that some UCP1+ adipocytes develop from
smooth muscle cells following extended cold-exposure (Long et al., 2014). Notably, there
exists controversy as to whether the cells identified in the studies above are bona fide
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smooth muscle cells or simply fibroblastic cells that express mural gene expression at
levels sufficient to trigger Cre expression.
Our group has demonstrated that a subset thermogenic adipocytes that develop
during cold exposure come from Pdgfra+ cells (Wang et al., 2019). Further work from the
Rodeheffer group has suggested that Pdgfra+ cells develop into white adipocytes in vivo,
and proposed that there may be a lineage hierarchy with cells more or less committed to
the adipocyte lineage based on markers identified with a candidate driven approach (Berry
and Rodeheffer, 2013; Rodeheffer et al., 2008). Notably, there was a recent report of a
myogenic cell serving as a progenitor cell for a unique glycolytic beige fat cell in a white
adipose depot (Chen et al., 2019). These myogenic cells only made adipocytes in the
absence of beta-adrenergic signaling and their physiologic relevance in wild-type mice
remains to be determined (Chen et al., 2019). Taken together, the precise identity of beige
adipogenic progenitor cells in vivo remains unknown. Further studies analyzing the extent
to which these tamoxifen-inducible CreER alleles are expressed in other cell types in an
unbiased manner would provide insight into the seemingly discordant observations
reported by investigators.
Using these in vivo models to study adipose progenitor cells, groups have
identified many factors and signaling pathways that control the development of
thermogenic adipocytes in white adipose tissues. Several investigators have studied the
impact of signaling pathways controlling the cell fate of progenitor cells. The Graff group
used in vivo models to identify that TZDs control in vivo adipogenesis; however, they were
unable to identify the particular cells that responded to TZD treatment in vivo (Tang et al.,
2011). The Farmer group sought to determine how BMP7 controls an adipogenic cell fate
decision in stromal cells (McDonald et al., 2015). Interestingly, they identified that BMP7
suppresses ROCK activity and ultimately acts to control Myocardin Transcription Factor A
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activity to promote adipogenesis (McDonald et al., 2015). This study suggested that
pathways initially discovered controlling iBAT differentiation likely also play a role in
thermogenic adipocyte differentiation in white adipose depots. Other groups, including our
own have identified that aging suppresses cold-induced beige adipogenesis in response
to cold or adrenergic stimulation (Berry et al., 2017; Wang et al., 2019). Identifying the
factors controlling this process remain of great interest to promote beige adipogenesis in
humans.
Recently investigators have used a new comprehensive unbiased technology,
single cell RNA sequencing, to profile stromal heterogeneity in various developing tissues.
Many groups have used these approaches to study stromal cells in adipose tissue, as
adipocytes tend to be too large to flow through the microfluidic channels of the single cell
capture devices (Burl et al., 2018; Hepler et al., 2018; Merrick et al., 2019; Schwalie et al.,
2018). Much effort has been dedicated to using these single cell technologies to identify
cell surface markers of transcriptionally different cellular populations to determine if they
display distinct in vitro or in vivo adipogenic phenotypes. These studies have revealed
better markers of fibroblastic cells that exist along a lineage trajectory towards becoming
adipocytes. Notably, there appears to be a conserved lineage hierarchy of fibroblastic cells
that are more committed to becoming adipocytes that express adipogenic genes including
Pparg and Lpl and are quite adipogenic in vitro and in vivo (Burl et al., 2018; Hepler et al.,
2018; Merrick et al., 2019). On the other end of the spectrum there exists a population of
fibroblastic cells with intermediate adipogenic potential that express of Pi16 and Wnt2 and
have the capacity to make Pparg+ fibroblast in vivo (Merrick et al., 2019). The location of
these Pi16/Wnt2+ cells in the developing subcutaneous white adipose tissue is notable in
that they are located on the edge of the developing adipose tissue as opposed to around
blood vessels (Merrick et al., 2019). Interestingly, there exists a third fibroblastic cell type
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marked by expression of F3; this fibroblastic population has been deemed both adipogenic
and anti-adipogenic by different groups and its physiologic relevance remains to be
determined (Schwalie et al., 2018). Future studies will be required to determine which of
these cells make adipocytes in vivo and what signaling pathways direct them towards
these distinct cellular states.
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ABSTRACT
Brown adipose tissue (BAT) activity protects animals against hypothermia and
represents a potential therapeutic target to combat obesity. The transcription factor Early
B Cell Factor-2 (EBF2) promotes brown adipocyte differentiation, but its role in maintaining
brown adipocyte fate and in stimulating BAT recruitment during cold exposure were
unknown. We found that deletion of Ebf2 in adipocytes of mice ablates BAT character and
function, resulting in cold-intolerance. Unexpectedly, prolonged exposure to cold restores
the thermogenic profile and function of Ebf2 mutant BAT. Enhancer profiling and genetic
assays identified EBF1 as a candidate regulator of the cold response in BAT. Adipocytespecific deletion of both Ebf1 and Ebf2 abolishes BAT recruitment during chronic cold
exposure. Mechanistically, EBF1/2 promotes thermogenic gene transcription through
increasing the expression and activity of ERRa and PGC1a. Together, these studies
demonstrate that EBF proteins specify the developmental fate and control the adaptive
cold response of brown adipocytes.

34

INTRODUCTION
Brown adipose tissue (BAT) thermogenesis protects animals against hypothermia
during cold exposure and is associated with resistance to obesity (Harms and Seale, 2013;
Yoneshiro et al., 2013). Brown adipocytes are packed with mitochondria that contain
Uncoupling Protein-1 (UCP1).

When activated, UCP1 dissipates the mitochondrial

membrane potential, which creates a driving force to burn large amounts of glucose and
fatty acids, generating heat as a byproduct. The therapeutic potential of BAT to reduce
metabolic disease has motivated great interest in defining the pathways that control the
development and function of brown adipocytes.
BAT depots develop prenatally in mice, providing newborns with an increased
capacity for non-shivering thermogenesis.

Cold exposure is the major physiological

activator of BAT thermogenesis. Cold exposure-induced beta-adrenergic signaling in
brown adipocytes drives lipolysis, substrate oxidation and uncoupled respiration (Cannon
and Nedergaard, 2004). Beta-adrenergic signaling also increases the expression of Ucp1
and mitochondrial genes in adipocytes to augment BAT capacity.
Distinct transcriptional pathways regulate the development and thermogenic
activation of brown adipocytes in response to stimulation. The p38 MAPK signaling
cascade plays a critical role in mediating thermogenic gene activation in response to betaadrenergic agonists (Cao et al., 2004). p38 phosphorylates Activating transcription factor
2 (ATF2) and Peroxisome proliferator-activated receptor gamma (PPARg) coactivator 1a
(PGC1a) to increase the transcription of Ucp1 and other mitochondrial genes. Other
transcription factors also promote thermogenic gene induction in response to betaadrenergic agonists, including the Estrogen Related Receptors (ERRs), CREB, ZFP516
and IRF4 (Ahmadian et al., 2018; Brown et al., 2018; Dempersmier et al., 2015; Emmett
et al., 2017; Kong et al., 2014; Kozak et al., 1994; Yubero et al., 1994).
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We previously identified the transcription factor Early B Cell Factor-2 (EBF2) as an
important regulator of brown fat cell commitment. EBF2 expression is enriched in brown
relative to white fat precursor cells and adipocytes (Rajakumari et al., 2013; Wang et al.,
2014). Ectopic expression of EBF2 in white fat precursors or muscle cells promotes brown
adipocyte differentiation (Rajakumari et al., 2013; Stine et al., 2016). Over-expression of
EBF2 or deletion of the EBF-repressor ZFP423 in the WAT of mice stimulates browning
and suppresses the development of obesity (Shao et al., 2016; Stine et al., 2016). Wholebody knockout (KO) of Ebf2 impairs fetal brown fat development (Rajakumari et al., 2013;
Wang et al., 2014). However, EBF2 is expressed in various cell types, precluding studies
addressing the physiologic role of EBF2 in regulating BAT activity of adult mice.
Here, we define a critical requirement for EBF2 in establishing and maintaining the
thermogenic character of brown adipocytes under basal conditions. Deletion of Ebf2 in
adipocytes of mice ablated BAT activity, causing cold-intolerance. Interestingly, sustained
cold exposure restored the thermogenic profile and function of Ebf2-mutant BAT.
Enhancer activity analyses identified enrichment of DNA-binding motifs for EBF and ERR
in mutant BAT in response to cold exposure, implicating a potential role for the related
EBF family member, EBF1. Deletion of EBF1 alone in adipocytes had minor effects on
BAT. However, concurrent deletion of EBF1 and EBF2 caused a complete loss of brown
fat thermogenic fate and ablated BAT recruitment during chronic cold exposure.
Mechanistic studies showed that EBF1 or EBF2 enhances the activity and expression of
the cold-induced transcription factors ERRa and PGC1a to stimulate Ucp1 transcription.
Together, these studies demonstrate that EBF proteins control basal and cold-induced
thermogenic gene programing in adipocytes.
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RESULTS
Adipocyte EBF2 controls adaptive thermogenic responses
To evaluate the role of EBF2 in regulating the thermogenic programing of adipocytes,
we generated adipocyte-specific Ebf2-mutant mice using the Adipoq-Cre driver strain
(Ebf2DAdipoq).

Ebf2 expression was decreased in the BAT of Ebf2DAdipoq mice, but

unaffected in the stromal-vascular fraction (SVF) of BAT, which contains brown
preadipocytes (Fig. 2.1A, 2.2A). By contrast, Myf5-Cre, which expresses in embryonic
brown fat progenitor cells, decreased Ebf2 expression in BAT SVF (Fig. 2.1A). At late
stages of fetal development, the BAT of Ebf2DAdipoq mice had higher lipid content and
reduced eosinophilic (mitochondrial) staining compared to BAT from control mice (Fig.
2.1B). Ebf2DMyf5 and Ebf2DAdipoq mutant BAT at this stage expressed greatly reduced levels
of Ucp1 and the mitochondrial marker Cytochrome C (Cycs) along with elevated levels of
the white adipocyte marker Resistin (Retn), relative to wildtype controls (Fig. 2.2).
Additionally, BAT from Ebf2DAdipoq mice displayed a near-complete loss of UCP1 protein
expression and lower levels of many mitochondrial respiratory chain proteins (Fig. 2.1C).
Conversely, the complex V protein ATP5a, which is normally expressed at low levels in
brown relative to white fat, was upregulated in Ebf2-mutant BAT (Fig. 2.1C). Transmission
electron microscopy analyses showed that the BAT of Ebf2DAdipoq mice had greatly
diminished mitochondrial density and larger lipid droplets (Fig. 2.1D).
The BAT of adult (8- to 10-week-old) Ebf2DAdipoq mice also expressed lower levels of
thermogenic and mitochondrial genes, including a ~80% reduction of Ucp1 relative to that
in control animals (Fig. 2.1E). Moreover, Ebf2 mutant BAT expressed diminished levels
of several transcriptional regulators of mitochondrial biogenesis, including Esrra, Esrrg,
and Ppargc1b, (Fig. 2.1E). White fat-enriched genes, including Adipoq and Retn, were
upregulated in Ebf2-mutant BAT (Fig. 2.1E).

37

Upon acute exposure to 4°C, Ebf2DAdipoq mutant mice experienced a greater decline
in body temperature compared to control mice, indicative of cold intolerance (Fig. 2.1F).
We further assessed the thermogenic capacity of control and mutant mice in response to
norepinephrine (NE). NE augmented oxygen consumption by ~4-fold in control animals
and this response was markedly blunted in Ebf2DAdipoq mice (Fig. 2.1G). Altogether, these
results demonstrate that adipocyte-EBF2 is required to establish and maintain the
thermogenic function of brown adipocytes.

38

Fig. 1

A

B

Relative mRNA Levels

Stromal Vascular Fraction
1.5

Ebf2DAdipoq

Ebf2WT
Ebf2DAdipoq
Ebf2DMyf5

1.0

0.5

C

Ebf2WT

***

0

Ebf2

BAT (Newborn)

D

Ebf2DAdipoq

Ebf2WT

Ebf2WT

Ebf2DAdipoq

UCP1

L

BAT (Newborn)

CV-ATP5A
CIII-UQCRC2
CIV-MTCO1
CII-SDHB
L

CI-NDUFB8
L

Transmission Electron Microscopy

TUBULIN

Relative mRNA Levels

E

1.5

Adult BAT: Gene Expression

Ebf2WT
Ebf2DAdipoq

1.5

**

0.5

*

0.5

Ebf2

Ucp1

0

Cidea

**
***

**

****

Esrra

***

G

Cold Tolerance

35

5
0

****
Adipoq

Retn

White adipocyte genes

****

4000

*

VO2 (ml/kg)

**

10

Thermogenic Capacity
5000

***

*

**

Mitochondrial genes

40

Body Temperature (oC)

***

Esrrg Ppargc1b mtCytb mtCo1 Cox7a1 Cycs

Brown adipocyte genes

F

****

15

1.0

1.0

0

20

30

3000

Ebf2WT
Ebf2DAdipoq

NE

2000
1000

25

0
0

1

2

3

4

5

0

6

Hours of cold exposure

13 26 39 52 65 78 91 104
Minutes after NE injection

Figure 2.1: Adipocyte EBF2 controls BAT thermogenic gene expression and activity
A) Ebf2 mRNA levels in Stromal-Vascular Fraction of BAT from 3-4 week old Ebf2WT,
Ebf2DMyf5, and Ebf2DAdipoq mice (n=3-5 mice per group; Mean+/-SEM). B) Hematoxylin and
eosin staining of BAT from P0.5 Ebf2WT and Ebf2DAdipoq mice (Scale Bar=100 um). C)
Western Blot analysis of UCP1 and mitochondrial respiratory chain components in BAT
from P0.5 Ebf2WT and Ebf2DAdipoq mice. D) Electron micrographs of BAT from P0.5 Ebf2WT
and Ebf2DAdipoq mice (Scale Bar = 500 nm). E) Relative mRNA levels of indicated genes in
BAT from 8- to 10-week-old Ebf2WT, Ebf2DAdipoq mice housed at room temperature
(RT/24oC) (n=5 mice per group; Mean+/-SEM). F) Cold tolerance test in RT-acclimated,
8- to 10-week-old Ebf2WT, Ebf2DAdipoq mice (n=8-10 mice per group; Mean+/-SEM). G)
Volume of O2 (VO2) consumed following norepinephrine (NE) treatment of Ebf2WT and
Ebf2DAdipoq mice housed at RT (n=7-10 mice per group; Mean+/-SEM).
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An EBF2-independent pathway mediates chronic cold-induced BAT recruitment
Mice housed at room temperature (22°C) experience mild cold stress, characterized
by constitutive BAT activation (Feldmann et al., 2009). To determine if EBF2 regulates
BAT fate under basal (unstimulated) conditions, we housed Ebf2WT and Ebf2DAdipoq mice
at 30°C, near their thermoneutral point. At this temperature, Ebf2-mutant BAT displayed
an even more pronounced loss of thermogenic character, compared to the effects at 22°C.
This included a dramatic morphologic conversion of BAT to WAT-like tissue, characterized
by increased lipid deposition, a near-complete loss of Ucp1 mRNA and protein expression
and diminished levels of mitochondrial genes (Fig. 2.3A-C). Ucp1 mRNA levels were
reduced by ~16-fold in Ebf2-mutant vs. control BAT in thermoneutral-housed mice,
compared to a ~3-fold reduction observed at room temperature (Fig. 2.3B).
The capacity for moderate cold exposure to increase the thermogenic profile of Ebf2
mutant BAT led us to examine the effects of chronic exposure to more severe cold.
Following exposure to 4°C for one week, the BAT of both Ebf2WT and Ebf2DAdipoq mice
assumed the histological appearance of thermogenically active tissue, including depleted
lipid content and dense eosinophilic staining (Fig. 2.4A). Ucp1 and Cycs were induced to
similarly high expression levels in control and Ebf2-mutant BAT (Fig. 2.3D). UCP1 and
mitochondrial proteins were also expressed at equivalent levels in control and Ebf2-mutant
BAT following cold exposure (Fig. 2.3E). Finally, cold exposure normalized Retn
expression in Ebf2-mutant BAT (Fig. 2.3D).
We next assessed if long-term cold exposure normalized the thermogenic capacity of
Ebf2DAdipoq mice. As shown above, NE increased oxygen consumption to a much greater
extent in control vs. Ebf2-mutant animals housed at 22°C (room temperature) (Fig. 2.3F).
Following housing at 4°C for 7 days, NE raised oxygen consumption to similarly high levels
in control and mutant animals (Fig. 2.3F).

41

There were no statistically significant

differences in oxygen consumption between cold-acclimated control and mutant mice at
any time points.

To assess if one bout of cold exposure permanently restored the

thermogenic program in Ebf2-mutant BAT, we cold-exposed mice for one week and then
re-acclimated them to room temperature for another week. The BAT of the “re-warmed”
Ebf2DAdipoq mice (4C→RT) expressed lower levels of thermogenic genes than control mice,
similar to the pattern observed in cold-naïve mice (Fig. 2.3G). These findings show that
sustained cold exposure enables Ebf2-independent thermogenic gene expression and
function in BAT.
In addition to driving BAT recruitment, cold exposure elicits the development of
UCP1+ multilocular “beige” adipocytes in white adipose tissue (WAT) depots. Adipocyte
Ebf2-deficiency caused a marked decrease in beige adipocyte formation and Ucp1
expression in inguinal WAT (iWAT) during cold exposure (Fig. 2.4B-D). The loss of Ebf2
in adipocytes did not affect either basal or beta-3-adrenergic agonist stimulated lipolysis
in epididymal adipose tissue (Fig.2.4). Moreover, adipocyte Ebf2-deficiency did not affect
body weight or composition in mice housed at room temperature (Fig. 2.4F).
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Figure 2.3. EBF2 is not required for chronic cold-induced thermogenic BAT
recruitment. A) Hematoxylin and eosin staining of BAT in Ebf2WT and Ebf2DAdipoq mice
housed at RT or 30oC (thermoneutrality (TN)) for one month (Scale Bar=100 um). B)
Relative mRNA levels of Ebf2, Ucp1 and Cycs in BAT from Ebf2WT and Ebf2DAdipoq mice
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UCP1 and mitochondrial respiratory chain components in BAT from Ebf2WT and Ebf2DAdipoq
mice housed at RT or TN. Tubulin was used for loading control. D) Relative mRNA levels
of indicated genes in BAT from Ebf2WT and Ebf2DAdipoq mice housed at RT or 4oC for one
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The classic thermogenic program in adipocytes is dispensable for high fat diet-induced
thermogenesis
High fat or cafeteria (high fat, high sugar) diets increase energy expenditure, though
the contribution of BAT thermogenesis or UCP1 to this process is debated (AnunciadoKoza et al., 2008; Feldmann et al., 2009; Kazak et al., 2017; Kontani et al., 2005; Ma et
al., 1988; Rothwell and Stock, 1979). To test if the increase in energy expenditure induced
by high fat diet (HFD) depends on EBF2-action in adipocytes, we housed Ebf2WT and
Ebf2DAdipoq mice at 30°C (to exempt them from cold stress) and fed them a HFD (Fig. 2.5A).
Under these experimental conditions, the BAT of mutant mice expressed greatly reduced
levels of UCP1 and mitochondrial genes and higher levels of Retn compared to controls
(Fig. 2.5B). Ebf2 mutant animals also displayed a severe reduction in NE-stimulated
oxygen consumption (Fig. 2.5C). Despite this deficit in BAT activity, Ebf2-mutant mice
gained similar amounts of body weight as control animals (Fig. 2.5D). Control and Ebf2
mutant animals also had similar blood glucose and insulin levels under both fasting and
re-fed conditions (Fig. 2.5E,F). Daily energy expenditure during HFD-feeding was
equivalent between control and mutant mice (Fig. 2.5G). During the switch from normal
chow to HFD, oxygen consumption increased and respiratory exchange ratio decreased
to a similar extent in control and mutant animals (Fig. 2.5H-J). Overall, these findings
indicate that the EBF2-driven BAT thermogenic program (including UCP1) is not essential
for HFD-induced thermogenesis.
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EBF activity controls basal and adaptive thermogenic gene expression
To investigate the mechanism responsible for Ebf2-independent BAT recruitment, we
performed unbiased gene expression profiling of BAT from Ebf2WT and Ebf2DAdipoq mice at
room temperature and following cold exposure (Fig. 2.6A). Clustering analysis identified
a large set of genes (light green cluster) that were induced by cold to a similar extent in
control and Ebf2-mutant BAT. This cluster was enriched for genes involved in oxidative
metabolism and mitochondrial activity, including Ucp1, Ppargc1b, Esrra, and Esrrg (Fig.
2.6B,C). To identify EBF2- and cold-regulated enhancers, we profiled the genome-wide
levels of H3K27-acetylation (H3K27ac) in BAT. Genomic regions with reduced levels of
H3K27ac in Ebf2-mutant vs. control BAT at room temperature were enriched for the EBF
binding motif, suggesting that EBF2 functions as a transcriptional activator at many of
these sites (Fig. 2.6D). Regions with higher H3K27ac levels in control BAT during cold
exposure (cold-induced) were enriched with binding motifs for the Estrogen related
receptors (ERRs), Thyroid hormone receptor (TR) and IRX3 (Fig. 2.6E). Of note, the coldinduced H3K27ac regions in Ebf2-mutant BAT were enriched for an EBF motif (Fig. 2.6F),
leading us to consider whether cold engages the activity of another EBF family member.
Early B Cell Factor 1 (EBF1) is highly expressed in adipocytes and is known to
regulate white adipocyte differentiation (Akerblad et al., 2002; Griffin et al., 2013; Jimenez
et al., 2007). To determine if EBF1 regulates brown adipocyte fate, we generated
adipocyte-specific Ebf1 mutant (Ebf1DAdipoq) mice. The BAT of Ebf1DAdipoq mice did not
display altered expression of Ebf2, Ucp1, Cycs or Retn at room temperature (Fig. 2.6G).
Additionally, the levels of UCP1 and mitochondrial proteins were unaffected by loss of
Ebf1 (Fig. 2.7A). At thermoneutrality (30°C), the BAT of Ebf1-mutant mice displayed a
modest reduction in Ucp1 expression and elevated Retn levels (Fig. 2.7B). To determine
if EBF1 compensates for the loss of EBF2 to mediate BAT recruitment during cold
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exposure, we generated adipocyte-specific Ebf1/Ebf2 double knockout (Ebf1/2DAdipoq)
mice. At room temperature, concurrent loss of Ebf1 and Ebf2 resulted in a greater
reduction of Ucp1 and increase in Retn expression in BAT, as compared with loss of Ebf2
alone (Fig. 2.7C). As observed before, control and Ebf2 single mutant BAT adopted the
characteristics of thermogenically active tissue following chronic cold exposure, including
lipid depletion and dense eosinophilic staining (Fig. 2.6H). By contrast, Ebf1/2 double
mutant BAT retained a white fat-like morphology and did not lose its lipid stores during
cold exposure (Fig. 2.6H).

The induction of Ucp1 expression in response to cold was

nearly absent in Ebf1/2 double mutant BAT (Fig. 2.6I, 2.7D). Moreover, cold failed to
normalize the expression of Esrra or Esrrg in the BAT of Ebf1/2 DKO animals (Fig. 2.6I).
These results demonstrate that EBF1 or EBF2 is required for cold-stimulated BATrecruitment.
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EBF2 cooperates with PGC1a and ERRa to promote Ucp1 expression
Lastly, we sought to determine the mechanism by which EBF proteins control the
cold-induced expression of Ucp1. The -6 kb Ucp1 enhancer is occupied by EBF2, ERRa
and the adipocyte-determination factor PPARg in BAT (Fig. 2.8A) (Emmett et al., 2017;
Shapira et al., 2017). Motif analyses of cold-induced enhancers in BAT identified high
enrichment of ERR binding sites, raising the hypothesis that EBFs cooperate with ERRa
and its co-activator partner PGC1a to stimulate transcription (Fig. 2.6D-F). The -6 kb Ucp1
enhancer contains putative DNA binding sites for EBF2 and ERR (Fig. 2.8B). In reporter
gene assays, we found that either EBF2 or EBF1, while having little activity on their own,
synergized with PGC1a or PGC1b to strongly activate transcription from the -6kb Ucp1
enhancer (Fig. 2.8C, 2.7E). The addition of ERRa further enhanced the transcriptional
activity of EBF2 and PGC1a/b (Fig. 2.8C, 2.7E). EBF1 and EBF2 were also able to
synergize with PGC1a/b to activate the -6kb Ucp1 enhancer (Fig. 2.7F,G).
To determine the nature of this cooperativity, we tested the transcriptional activity of
various mutant forms of EBF2. EBF2 R162A, which contains a mutation in the DNA
binding domain, was unable to cooperate with PGC1a to activate transcription (Fig. 2.8D).
Deletion of the C-terminal serine/proline transactivation domain did not affect EBF2
transcriptional activity (Fig. 2.8D). To test if EBF2 enhances the function of an
ERR/PGC1a complex, we mutated a candidate ERR binding site within the -6k Ucp1
enhancer (Fig. 2.8B). Deletion of this site eliminated the ability of ERRa/PGC1a to activate
transcription, validating it as a functional ERRa site (Fig. 2.8E). Mutation of this site also
largely abolished the capacity for EBF2 or EBF1 to cooperate with PGC1a and stimulate
transcription (Fig. 2.8F, 2.7H). Notably, EBF2 still efficiently cooperated with PPARg to
activate transcription from the mutant enhancer, suggesting distinct sites for EBF2 action
(Fig. 2.8H). To determine if ERRa expression was required for the transcriptional activity
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of EBF2 and PGC1a, we performed transcription assays in Esrra-mutant cells (Fig. 2.7I,J).
In the absence of ERRa, EBF2 was unable to cooperate with PGC1a or efficiently promote
transcription from the Ucp1 enhancer (Fig. 2.8I). Altogether, these results indicate that
EBF2 enhances the transcriptional activity of an ERRa/PGC1a complex to drive Ucp1
transcription (Model, Fig. 2.8I).
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DISCUSSION
This study reveals that EBF proteins control the thermogenic gene program in
adipocytes during development and in response to environmental cold. Adipocyte-EBF2
is essential for maintaining brown fat fate in mice housed under standard conditions,
ensuring proper thermogenic function and tolerance upon cold challenge. Chronic cold
exposure recruited BAT activity through a pathway that depended on either EBF1 or
EBF2.
Non-shivering thermogenesis in BAT has been suggested to counteract weight gain.
While the EBF2-driven thermogenic program in adipocytes was essential for cold
tolerance in mice, this program (including UCP1 expression) was dispensable for HFDinduced thermogenesis. We found that HFD induced an equivalent increase in oxygen
consumption and shift to higher fatty acid utilization in control and Ebf2 mutant mice.
Several studies have described UCP1-independent forms of energetic uncoupling in
adipocytes, which could mediate HFD-induced thermogenesis and/or compensate for loss
of UCP1 (Anunciado-Koza et al., 2008; Flachs et al., 2013; Granneman et al., 2003; Ikeda
et al., 2017; Kazak et al., 2015, 2017; Long et al., 2016; de Meis, 2003; de Meis et al.,
2006; Ukropec et al., 2006). In particular, a creatine cycling pathway in adipocytes of mice
counteracts HFD-induced weight gain (Kazak et al., 2015, 2017, 2019). We speculate that
EBF2 controls the UCP1-based pathway in adipocytes, without influencing the activity of
other thermogenic pathways, such as the creatine cycle.
Cold exposure activates BAT and elicits the development of thermogenic UCP1+
(beige) adipocytes in WAT. While chronic cold exposure rescued BAT activity, it did not
restore beige adipocyte formation in Ebf2DAdipoq mice. This may be due to lower expression
and/or activity of other EBFs in WAT vs. BAT. Alternatively, WAT browning may rely more
on EBF2 due to the lower levels of sympathetic innervation and adrenergic stimulation in

54

WAT compared to BAT. Of note, cold-adapted Ebf2 mutant mice displayed the same
thermogenic capacity as wildtype animals despite a near-complete absence of UCP1
expression in WAT. This result suggests that BAT is the predominant source of
adrenergically stimulated thermogenesis during cold exposure. Alternatively, the level of
acute NE-stimulated thermogenesis could be limited by other factors, such as oxygen
delivery or blood flow, precluding the ability to detect a contribution from beige fat.
Genomic and transcriptional studies indicate that EBF proteins promote thermogenic
gene transcription through cooperation with members of the ERR and PGC1a protein
families, which are known to regulate the BAT cold response (Brown et al., 2018; Emmett
et al., 2017; Gantner et al., 2016; Kleiner et al., 2012). Our data support a model in which
EBF binding to thermogenic gene enhancers such as Ucp1 facilitates the binding and/or
transcriptional function of ERR/PGC1a (Fig. 2.8I). We previously showed that EBF2
associates with the BAF chromatin-remodeling complex to increase PPARg activity during
brown adipocyte differentiation. A similar mechanism may enhance ERR/PGC1a activity
at thermogenic genes during cold exposure. In support of this, BRG1, a member of the
BAF chromatin-remodeling complex, is recruited to brown adipocyte enhancers in
response to beta-agonist treatment (Abe et al., 2015).

In addition to regulating the

transcriptional activity of ERR/PGC1, EBF1/2 promotes the expression of Esrra, Esrrg,
and Ppargc1b, establishing a feed forward loop to drive the BAT cold response. It is yet
unknown whether cold enhances the chromatin binding or remodeling activity of EBFs.
In summary, our data highlight the critical function of EBF proteins in regulating the
basal and adaptive thermogenic gene programs in BAT. Identification of the factors that
stimulate EBF expression and/or activity in adipocytes may thus reveal new approaches
to increase BAT activity for the treatment of obesity and related disease.
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ABSTRACT
Brown adipose tissue can expend large amounts of energy and thus increasing its amount
or activity is a promising therapeutic approach to combat metabolic disease. In humans,
major deposits of brown fat cells are found intimately associated with large blood vessels,
corresponding to perivascular adipose tissue (PVAT). However, the cellular origins of
PVAT are poorly understood. Here, we applied single cell transcriptomic analyses, ex vivo
adipogenesis assays, and genetic fate mapping in vivo to determine the identity of
perivascular adipocyte progenitors. We found that thoracic PVAT initially develops from a
fibroblastic

lineage,

comprising

progenitor

cells

(Pdgfra+;Ly6a+;Pparg-)

and

preadipocytes (Pdgfra+;Ly6a-;Pparg+). Progenitors and preadipocytes in PVAT shared
transcriptional similarity with analogous cell types in white adipose tissue, pointing towards
a conserved adipose cell lineage hierarchy. Interestingly, the aortic adventitia of adult
animals contained a novel population of adipogenic smooth muscle cells (Myh11+; Pdgfra; Pparg+) possessing the capacity to generate adipocytes in vitro and in vivo. Taken
together, these studies define distinct populations of fibroblastic and smooth muscle
progenitor cells for thermogenic PVAT, providing a crucial foundation for developing
strategies to augment brown fat activity.
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INTRODUCTION
Thermogenic adipose tissue protects animals against hypothermia during cold
exposure and is associated with resistance to obesity and metabolic syndrome in humans
(Cypess et al., 2015; Harms and Seale, 2013; O’Mara et al., 2020; Yoneshiro et al., 2013).
Thermogenic adipocytes have large numbers of mitochondria that contain Uncoupling
Protein 1 (UCP1). Upon activation, UCP1 uncouples the mitochondrial proton gradient
from ATP synthesis, creating an electrochemical driving force to burn large amounts of
fatty acids and glucose for heat production (Cannon and Nedergaard, 2004). Additional
thermogenic mechanisms, including creatine and calcium-driven futile cycles have also
been described in adipocytes (Ikeda et al., 2017; Kazak et al., 2015, 2017). The
therapeutic potential of thermogenic adipose tissue to suppress metabolic disease has
spurred great interest in identifying the cellular origin and developmental pathways of
thermogenic adipocytes.
Multiple discrete thermogenic adipose depots can be activated by cold exposure or
beta-adrenergic activators in humans (Cypess et al., 2009; van Marken Lichtenbelt et al.,
2009; Sacks and Symonds, 2013; Virtanen et al., 2009). Infants have a thermogenic
adipose tissue depot in the interscapular region, analogous to the location of the largest
brown adipose tissue (BAT) depot in many rodent species (AHERNE and HULL, 1964;
Harms and Seale, 2013; Heaton, 1972; Orava et al., 2011; Wang and Seale, 2016).
However, the interscapular BAT pad regresses and becomes undetectable in adults (Lidell
et al., 2013). Adult humans retain BAT deposits in the supraclavicular region and in several
depots surrounding large blood vessels, known as perivascular adipose tissue (PVAT)
(Cypess et al., 2013, 2015; Huttunen et al., 1981). For example, UCP1+ adipocytes are
present within the carotid sheath and mediastinal cavity of humans (Cheung et al., 2013;
Cypess et al., 2013). PVAT in the thoracic peri-aortic region of human subjects increase
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glucose uptake in response to systemic administration of a beta-3-adrenergic receptor
agonist, a key functional attribute of BAT (Cypess et al., 2015). Therefore, understanding
the ontogeny and regulation of thermogenic PVAT may identify novel therapeutic targets
to combat metabolic disease.
Here, we performed a detailed analysis of peri-aortic adipose tissue development and
maintenance in mice. We found that the aortic adipose depot forms perinatally and
possesses characteristics of classical BAT, including: (1) stable expression of
thermogenic components in vivo and in vitro; (2) dependence on the brown adipocytelineage determining factor EBF2; (3) responsiveness to environmental cold; and (4)
resistance to high fat diet-induced inflammation. Single cell transcriptomic analysis of the
aorta and associated adventitia in the perinatal period identified several distinct cell types,
including presumptive preadipocytes, mesenchymal progenitor cells and three groups of
SMCs. Cell differentiation assays and genetic lineage tracing studies show that fibroblastic
progenitor cells but not SMCs are responsible for aortic PVAT organogenesis.
Interestingly, the aortic adventitia of adult animals lacks fibroblastic preadipocytes but
contains a novel population of adipogenic SMCs that can contribute to adipocyte
formation. Together, these studies identify and define multiple progenitor cell types for
thermogenic adipocytes in developing and adult PVAT.
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RESULTS
Aortic PVAT expresses an EBF2-dependent classical brown fat program
The aorta of adult mice is surrounded by multiple lobes of PVAT, all enclosed within
an anatomic compartment defining fascial layer (Fig. 3.1A). Histologically, perivascular
adipocytes have densely eosin-stained cytoplasm and contain multiple lipid droplets,
resembling brown adipocytes in interscapular BAT (iBAT). PVAT from the thoracic aorta
and iBAT expressed comparable levels of both common adipocyte genes (i.e. Adipoq and
Pparg2) and the brown fat marker gene Ucp1 (Fig. 3.1B). The thermogenic character of
aortic PVAT was further recruited by cold exposure. Specifically, aortic PVAT from coldexposed (4°C for 1 week) mice exhibited depleted lipid stores and expressed higher levels
of thermogenesis-related genes (Cycs, Ppargc1a, and Ucp1), as compared to that from
mice housed at thermoneutrality (30°C) (Fig. 3.1C,D).
The transcription factor Early B Cell Factor-2 (EBF2) is a critical regulator of
thermogenic adipocyte development (Rajakumari et al., 2013; Shapira et al., 2017; Stine
et al., 2016; Angueira et al., 2020). To determine if EBF2 controls PVAT fate, we analyzed
thoracic aortas from mice lacking Ebf2 expression in adipocytes (Ebf2DAdipoq) and littermate
control mice (Ebf2WT).

Aortic PVAT from Ebf2DAdipoq mice displayed a whitened

morphology, associated with increased lipid deposition (Fig. 3.1E). Ebf2 mutant tissue
also showed markedly reduced expression of brown fat-specific genes, including an ~80%
reduction of Ucp1 and lower levels of Cycs (Fig. 3.1F). In contrast to WAT depots, iBAT
is relatively resistant to inflammation triggered by a high fat or western diet (Dowal et al.,
2017; Lumeng et al., 2007; Tian et al., 2016; Weisberg et al., 2003). To determine if PVAT
is similarly protected from diet-induced inflammation, we fed C57/Bl6 mice a western diet
for 16 weeks (Fig 3.1G). As expected, western diet feeding promoted inflammation in
epididymal WAT, typified by the higher expression levels of macrophage and pro-
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inflammatory genes (“M1-like macrophage”) and decreased levels of anti-inflammatory
(“M2-like macrophage”) genes (Fig 3.1H) . By contrast, western diet feeding did not affect
the expression levels of various inflammatory or macrophage marker genes in thoracic
PVAT. Altogether, these findings demonstrate that aortic PVAT possesses many of the
phenotypic properties of classical BAT.
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Figure 3.1 Aortic PVAT expresses an EBF2-regulated classical brown fat
program. (A) H&E staining of thoracic aorta and iBAT from C57/Bl6 mice (scale
bar, 724.7 µm). (B) mRNA levels of indicated genes in thoracic PVAT, iBAT, and
iWAT from C57/Bl6 mice. (n=5 mice per group; mean+/- SEM). (C, D) H&E staining
(C) and mRNA levels of indicated genes (D) in thoracic aorta from
thermoneutrality-acclimated C57/Bl6 mice housed at thermoneutrality or 4oC for
one week. (n=6 mice per group; mean+/- SEM; scale bar, 100 µm).(E, F) H&E
staining of thoracic aorta (E) and mRNA levels of indicated genes in aortic PVAT
(F) from Ebf2WT and Ebf2DAdipoq mice (n=5 mice per group; mean+/- SEM; scale
bar, 362.3 µm).(G) Body weights of C57/Bl6 mice fed normal chow or western diet
for 16 weeks (n=8 mice per group; mean+/-SEM)(H) mRNA levels of indicated
genes in eWAT and thoracic PVAT from C57/Bl6 mice fed normal chow or western
diet for 16 weeks. (n=6 mice per group; mean+/- SEM). PVAT; Perivascular
Adipose Tissue; Lu; vessel lumen
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Identification of fibroblast heterogeneity in developing aortic PVAT
We next sought to identify the progenitor cells responsible for the genesis of PVAT.
Histologic examination of thoracic aorta from embryonic day 18 (E18) embryos (just prior
to birth) revealed an extensive network of adventitial fibroblasts and well-developed aortic
SMCs but an absence of lipid-containing adipocytes (Fig. 3.2A). During the perinatal
period after birth (P1-P3), we found prominent lobes of multilocular adipocytes, organized
in a stereotyped pattern around the aorta (Fig. 3.2A). Consistent with this histological (or
anatomical) observation, there was a dramatic rise in the expression levels of adipocyteand brown fat-marker genes (Adipoq, Leptin (Lep), Pparg2, Ucp1) in thoracic aortas
between E18 and P3 (Fig. 3.2B).
To identify vascular adipocyte progenitor cells, we performed single cell RNA
sequencing (scRNAseq) of all stromal-vascular cells isolated from the thoracic aorta at
E18 and P3. We reasoned that these analyses would detect major shifts in the cellular
composition of aortic tissue between E18 and P3, as the adipose tissue depot forms.
Surprisingly, integration of the E18 and P3 scRNAseq datasets revealed nearly identical
cell population structures (Fig. 3.3A-F) (Stuart et al., 2019). The only notable difference
was the emergence of greater numbers of Adipoq+ and Adipoq+/Ucp1+ cells in the P3
dataset relative to E18 (Fig. 3.3F). We presume that the Adipoq-expressing cells present
at E18 represent small nascent adipocytes that co-purified with stromal-vascular cells.
We focused our subsequent analysis on the P3 dataset given its greater
representation of Adipoq/Ucp1+ adipocytes. Clustering analysis identified several
expected cell populations, including endothelial cells, immune cells, mesothelium and
neuronal cells (Fig. 3.2C, 3.3G). There was also a connected array of fibroblast cell
clusters positioned between SMCs and adipocytes, including Intermediate Cells,
Progenitors and Preadipocytes (Fig. 3.2C). Clustering analysis identified three groups of
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SMCs, all of which were marked by expression of the pan smooth muscle genes Myh11
and Acta2 (Fig 3.2D). MYH11+ SMCs were located around the aorta and did not express
PDGFRa, a marker of fibroblast cells (Fig. 3.2D). Adipocytes were marked by specific
expression of Adipoq and Perilipin-1 (Plin1) (Fig. 3.2E). PLIN1-expressing adipocytes
were exclusively located within adipose tissue lobes near the aorta (Fig. 3.2E). Among
the fibroblast groups, we identified a putative population of preadipocytes that clustered
closest to adipocytes and expressed the master adipogenic regulator Pparg and the
fibroblast marker Pdgfra (Fig. 3.2F). Co-staining of PPARg and PDGFRa in thoracic aorta
revealed that preadipocytes were located at the periphery of the developing adipose tissue
lobes (Fig. 3.2F). Another population of fibroblastic cells, which we termed intermediate
cells, clustered closest to the SMCs and were marked by selective expression of Bace2
and Clec11a (Fig. 3.2G). Intermediate cells also expressed Acta2, albeit at lower levels
than SMCs. In situ mRNA hybridization analysis revealed that Bace2-expressing cells
were intimately associated with the outer wall of the aorta (Fig. 3.2G). The third fibroblast
population, which we called progenitors, expressed enriched levels of Pi16 and Ly6a (Fig
3.3D). Pi16 mRNA was localized in a majority of the adventitial cells surrounding the aorta.
Co-staining of Pi16 mRNA with the intermediate cell marker, Clec11a, revealed that
progenitor cells were located more distally to the aorta than intermediate cells (Fig. 3.2H).
Altogether, these analyses identified multiple fibroblast cell subtypes residing in discrete
anatomic compartments within the developing aorta and its associated tissues (Fig. 3.2I).
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Figure 3.2 Identification of multiple fibroblast populations in developing aortic
PVAT. (A) H&E staining of retroperitoneum en bloc from E18 and P3 CD1 mice (scale bar,
517.6 µm). (B) mRNA levels of indicated genes in thoracic from E18 and P3 CD1 mice
(n=3 biological replicates of pooled aortas; mean+/-SEM) (C) UMAP projection of
clustering of 17,957 cells from P3 thoracic aorta of P3 CD1 mice. (D) UMAP projections
showing expression of smooth muscle marker genes (left) and immunostaining of
PDGFRa (red), MYH11 (green), and DAPI (blue) in sections of E18 thoracic aorta (right)
(scale bar, 271.8 µm). (E) UMAP projections showing expression of adipocyte marker
genes (left) and immunostaining of PLIN1 (red) and DAPI (blue) in sections of P3 thoracic

65

aorta. (scale bar, 543.5 µm). (F) UMAP projections showing expression of preadipocyte
marker genes and immunostaining of PPARg (red), PDGFRa (green), and DAPI (blue) in
sections of P3 thoracic aorta. Arrowheads in inset show preadipocytes (scale bar, 135.9
µm). (G) UMAP projection showing expression of intermediate cell marker genes and
mRNA in-situ hybridization of Bace2 (red), and DAPI (blue) in sections of P3 thoracic
aorta. Arrowhead indicates intermediate cell. (scale bar, 145 µm). (H) UMAP projection
showing expression of progenitor marker genes (left) and mRNA in-situ of hybridization
of: (1) Pi16 (green), and DAPI (blue) (middle); and (2) Clec11a (red), Pi16 (green), and
DAPI (blue) (right) in P3 thoracic aorta. Arrowheads in [L] inset indicate progenitors. White
arrowheads point to intermediate cells. Yellow arrowhead shows progenitor cell (right).
(scale bar, 291 µm [L] and 145 µm [R]). (I) Model for thoracic aorta tissue organization at
P3. PVAT; Perivascular Adipose Tissue; Lu; vessel lumen.
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Isolation and characterization of adipogenic fibroblasts in perinatal thoracic aorta
We developed a fluorescence-activated cell sorting (FACS) strategy to isolate the
three fibroblast populations (intermediate cells, progenitors, preadipocytes) and SMCs,
based on their expression of cell surface markers. Dissociated cells from aortas were
stained with CD31, CD45, and Ter119 to separate away endothelial, immune, and
erythroid cells, respectively (Fig 3.5A). Progenitors were then identified and sorted based
on high expression of LY6A (Fig. 3.4A, left panel, 3.5B). Preadipocytes were isolated from
LY6A(-) cells based on the intermediate expression of CD142 and lack of CD200
expression (Fig. 3.4A, middle panel). SMCs were LY6A(-), CD200+ and CD142(-) (Fig.
3.4A, middle panel, 3.5C). Intermediate cells were purified from the CD200+;CD142+ cells
by gating against CD317+ mesothelial cells (Fig. 3.4A, right). We performed bulk RNA
sequencing on the four sorted cell populations to validate the sorting strategy and to obtain
deep expression profiles for comprehensive pathway analyses. The cluster-defining
genes identified from the single cell transcriptomes were mapped onto the sorted cell
transcriptomes, revealing a high level of concordance between single cell and sorted cell
gene expression profiles (Fig. 3.4B).
We compiled cell type-defining gene sets through differential gene expression
analyses of the bulk RNAseq datasets; these stringent gene lists only comprised genes
that were significantly and highly enriched in a cell type relative to all others (Fig. 3.4C).
Pathway analyses of these gene lists uncovered a variety of cell type-enriched pathways.
For example, “Calcium regulation” and “Striated Muscle contraction” were identified in
SMCs. Intermediate cells were enriched for components of the “Hedgehog signaling
pathway”. Progenitor cells demonstrated elevated expression of genes involved in
“Complement Activation” as well as “Endochondral ossification”. Preadipocytes were
notable for their enriched expression of genes related to “electron transport chain”,
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“oxidative phosphorylation”, and “TCA cycle”, corresponding to gene programs that are
critical for the activity of thermogenic adipocytes.
To investigate the adipogenic potential of sorted cell populations, we performed ex
vivo adipogenesis assays. Sorted cell populations were plated and treated with a standard
adipogenic cocktail to stimulate adipocyte differentiation. SMCs and intermediate cells
displayed almost no capacity to undergo adipocyte differentiation, as assayed by Bodipy
staining for lipid accumulation (Fig. 3.4D,E).

By contrast, progenitor cells and

preadipocytes efficiently formed adipocytes, with the preadipocytes displaying the highest
levels of adipogenesis (Fig. 3.4D,E). Overall, these studies provide a robust method for
purification of specific aorta-associated cell populations and reveal a gradient of
adipogenic competency from non-adipogenic SMCs to highly adipogenic preadipocytes.
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Smooth Muscle Cells (SMC) [LY6A-; CD142-; CD200+], Intermediate Cells (Int) [LY6A-;
CD142+; CD200+, CD317-]. Meso (Mesothelium) [LY6A-; CD142+; CD200+, CD317+].
(Representative plots from 10 separate experiments). (B) Expression heatmaps of Seuratgenerated cluster-defining genes mapped on to sorted-cell RNA-Seq results (n=3
biological replicates per group). (C) Pathway analysis of cluster-defining genes for each
cell population. Cluster-defining genes are defined as significantly differentially expressed
genes with log2FC>1.5 in every pairwise comparison from sorted-cell bulk RNA-seq (n=3
biological replicates). (D) Bodipy (lipid; green) and Hoechst (DNA; blue) staining of
indicated cell cultures following differentiation with adipogenic cocktail (Representative
image of 5 separate experiments). (E) Quantification of adipocyte differentiation of cultures
in [D] as Bodipy+ area above threshold/nuclear content (DAPI) (n=5 separate
experiments; mean+/-SEM).
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Figure 3.5: Purification of smooth muscle and fibroblastic cells from thoracic aortas
(Related to Fig. 3.4) (A) FACS isolation of fibroblastic and smooth muscle populations.
Dissociated cells were: (1) gated on SSC-A and FSC-A to exclude debris; (2) FSC-H vs.
FSC-W then SSC-H vs. SSC-W to isolate single cells; and (3) gated on Live (FVS510-)
Lin- (CD45-,CD31-,Ter119-) cells. Depicted sort gates were used to isolate the following
cell populations: Progenitors [LY6A high], Preadipocytes (PreAd) [LY6A-, CD142 mid;
CD200-]; Smooth Muscle Cells (SMC) [LY6A-; CD142-; CD200+], Intermediate Cells (Int)
[LY6A-; CD142+; CD200+, CD317-]. Meso (Mesothelium) [LY6A-; CD142+; CD200+,
CD317+]. (Representative image of 10 expts). (B) UMAP projection of P3 thoracic aorta
single-cell data showing expression of indicated genes used in the above sorting strategy.
Red circles represent presence of expression. Black circles indicate lack of expression.
Circles correspond to the following clusters from Fig 2: 1- Progenitor Cells, 2-SMCs, 3Intermediate Cells, 4 Preadipocytes and Adipocytes, 5-Mesothelium. (C) Immunostaining
of CD200 (red), MYH11 (green), and DAPI (blue) in sections of P3 thoracic aorta. White
arrowhead shows an Intermediate cell. Yellow arrowhead shows an SMC (scale bar,
65um; Lu: lumen).

71

Adipogenic fibroblasts represent the major source of aortic PVAT in neonates
The contribution of smooth muscle and fibroblastic cells to perivascular adipocyte
development was examined in vivo using genetic lineage tracing models (Fig. 3.6A). We
used Myh11-Cre mice to investigate if SMCs develop into peri-aortic adipocytes. Myh11
is a highly specific marker of SMCs and its expression was restricted to SMCs in our
scRNAseq data set (Fig. 3.7A) (Miano et al., 1994). Analysis of Myh11-Cre; tdTomato
reporter mice revealed uniform labeling of aortic smooth muscle. We did not detect any
tdTomato+ adipocytes around the aorta, implying that SMCs do not give rise to adipocytes
(Fig. 4B).
Pdgfra is expressed in all peri-aortic adventitial fibroblasts, including intermediate
cells, progenitors and preadipocytes (Fig. 3.7A). To evaluate the contribution of these cell
populations to adipocytes, we utilized tamoxifen-inducible Pdgfra-CreER; GFP reporter
mice (Pdgfra-CreER; mTmG). We administered one dose of tamoxifen to pregnant
females on E18 to induce GFP expression in fibroblast cells. Analysis of embryos 24h
later revealed extensive GFP expression in fibroblastic cells surrounding the aorta,
including cells in the anatomic locations characteristic of intermediate cells, progenitors
and preadipocytes (pulse) (Fig. 3.6C). In adult animals, we observed GFP expression in
many mature adipocytes (marked by PLIN1-expression), demonstrating that perivascular
adipocytes initially develop from an embryonically-specified Pdgfra+ fibroblastic lineage
(Fig. 3.6C).
RNAseq analysis identified Vipr2 as a selective marker gene of Intermediate cells
relative to the other fibroblast subpopulations (Fig. 3.7B). We used Vipr2-Cre;GFP reporter
mice to determine if intermediate cells develop into adipocytes. At P3, GFP expression
was confined to fibroblastic cells associated with the outer SMC layer of the aorta,
consistent with an intermediate cell identity. In adult mice, we observed a similar, robust
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pattern of GFP expression in fibroblast cells around the aorta, but an absence of GFP
expression in adipocytes (Fig. 3.6D). Progenitors and preadipocytes were enriched for
Penk expression, relative to other fibroblasts (Fig. 3.7A). In P3 Penk-Cre:GFP mice, GFP
was expressed in peri-aortic fibroblastic cells, with GFP labeling of adipocytes becoming
widespread in adulthood (Fig. 3.6E). Collectively, these experiments demonstrate that
peri-aortic adipose tissue develops from fibroblastic progenitor cells, specifically
progenitors and preadipocytes.
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Figure 3.6 Adipogenic fibroblasts are the major source of aortic adipocytes in
neonates (A) Schematic of cell types in perinatal aorta and corresponding marker genes
identified via RNA-Seq. (B) Immunostaining of PLIN1 (green), RFP (red) and DAPI (blue)
in sections of P3 thoracic aorta from Myh11-Cre(-); tdTom (control) and Myh11-Cre+;
tdTom reporter mice. White arrowhead in inset indicates labeled smooth muscle cells.
Yellow arrowhead shows the absence of traced (RFP+) adipocytes. (n=2 Cre-; n=3 Cre+;
scale bar, 271.8 µm). (C) Immunostaining of GFP (green), PLIN1 (red), and DAPI (blue)
in sections of thoracic aorta from Pdgfra-CreER(-); mTmG (control) and Pdgfra-CreER+;
mTmG mice harvested 24 hours (E18 Pulse) and 8 weeks (Adult Chase) following an E18
pulse with tamoxifen (100 mg/kg). Arrowhead in inset 1 indicates labeled fibroblasts.
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Arrowheads in inset 2 indicate GFP+ adipocytes. (Pulse: n=1 Cre-; n=3 Cre+; Chase: n=1
Cre-; n=2 Cre+; scale bar, 271.8 µm). (D) Immunostaining of GFP (green) and DAPI (blue)
in sections of P3 and adult thoracic aorta from Vipr2-Cre(-); mTmG and Vipr2-Cre+;
mTmG mice. Arrowheads indicate GFP expressing intermediate cells. (P3: n=3 mTmG-;
n=4 mTmG+; Adult: n=1 mTmG-; n=4 mTmG+; scale bar, 290 µm (P3), 724.7 µm (adult)).
(E) Immunostaining of GFP (green) and DAPI (blue) in sections of P3 and adult thoracic
aorta from Penk-Cre(-); mTmG and Penk-Cre+; mTmG+ mice. Yellow arrowheads
indicate labeled fibroblasts. White arrowheads indicate labeled adipocytes. (P3: n=1 Cre; n=3 Cre+; Adult: n=1 Cre-; n=3 Cre+; scale bar, 145um (P3), 724.7um (adult)). PVAT;
Perivascular Adipose Tissue; Lu; vessel lumen
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Figure 3.7: Expression profiles of Cre-driver mouse lines (Related to Fig. 3.6) (A)
UMAP projection showing expression of indicated genes used for Cre and CreER driver
mouse strains. (B) Log2FC expression analyses of Vipr in indicated cell types from sorted
cell bulk RNAseq datasets.
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Comparative analysis of thermogenic and white adipogenic progenitors
We next sought to determine whether perivascular progenitor cells were committed
to the thermogenic lineage. We isolated the adipogenic populations from thoracic aorta
(Progenitor and Preadipocyte) and preadipocytes from iWAT. These cell populations were
then induced to undergo adipocyte differentiation in culture. The PVAT populations and
iWAT cultures expressed comparable levels of general adipocyte marker genes (Adipoq,
Pparg2), indicative of similar adipogenic competency (Fig. 3.8A, 3.9A). Notably, PVAT
progenitors and preadipocytes but not iWAT preadipocytes adopted a thermogenic gene
program (Dio2, Ucp1) following adipocyte differentiation (Fig. 3.8A, 3.9A).
Developing PVAT and iWAT contain analogous adipogenic populations: progenitor
cells expressing genes such as Pi16 and Dpp4, and preadipocytes expressing
commitment markers Pparg and Lpl. To search for conserved gene programs controlling
these two cellular states, we performed bulk RNA sequencing on freshly sorted
progenitors and preadipocytes from aortic PVAT and iWAT. Principal component analysis
showed that tissue origin accounted for much of the variance in the expression of the 500
most variable genes (Fig. 3.9B). We defined a consensus gene signature of progenitors,
consisting of genes that were selectively expressed in progenitors vs. preadipocytes from
both PVAT and iWAT (Fig. 3.8C, 3.9B). Pathway analysis of these genes identified
enrichment of Prostaglandin synthesis, TGFb and WNT signaling (Fig. 3.8C). The
consensus preadipocyte genes were enriched for “PPAR signaling”, “adipogenesis”
(Pparg, Cd36, and Rxrg), and an unexpected signature of cell cycle activity (Mcm2,
Cdc45, and Rpa1) (Fig. 3.8D). Interestingly, PVAT preadipocytes specifically expressed
genes related to electron transport chain, oxidative phosphorylation and the TCA cycle,
including many genes important for the function (Cox5a, Cox7a2, and Ucp1) and
transcriptional control (Ppargc1a and Esrra) of brown adipocytes (Fig. 3.8D,E). These

77

data support a model in which uncommitted progenitor cells (enriched for expression of
anti-adipogenic WNT and TGFb pathways) develop into preadipocytes, with specific
induction of a thermogenic gene program in PVAT preadipocytes (Fig. 3.8F).
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Figure 3.8: Comparative gene expression profiling of white and brown adipogenic
cells (A) mRNA levels of indicated genes in differentiated adipocytes derived from the
following cell types of P3 CD1 mice: iWAT preadipocytes, thoracic perivascular
progenitors and thoracic perivascular preadipocytes. (n=4 independent wells from pooled
FACS populations per group; mean+/- SEM). (B) Principle component analysis (PCA) of
the top 500 differentially expressed genes in sorted cell RNA Seq. (n=3 biological
replicates per cell type). One PVAT PreAd datapoint includes two overlapping replicates.
(C) Venn diagram of genes enriched in progenitor populations relative to preadipocyte
populations from iWAT and PVAT. Pathway analysis of genes commonly enriched in both
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depots (significantly differentially expressed and LFC>0). (D) Venn diagram of genes
enriched in preadipocyte populations relative to progenitor populations. Pathway analysis
of genes commonly enriched in both depots (significantly differentially expressed and
LFC>0) (left) and genes unique to PVAT (right). (E) Z-Score split heatmap of
representative genes from GO analysis. Gene expression levels are calculated between
cell types (i.e. PVAT Progenitors vs. PVAT PreAd) within a depot of origin (n=3 biological
replicates per cell type). (F) Model for conserved ontogeny of adipose depot development.
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Identification of adipogenic smooth muscle cells in adult PVAT
To determine if the cell types observed in developing PVAT were also present in
adults, we performed scRNAseq on the stromal-vascular fraction of thoracic aorta from
13-week-old mice. Analysis of the adult dataset alone revealed many of the adult cell
groups were analogous to cell types observed in perinatal animals (Fig. 3.10A, 3.11A).
Clustering analysis revealed three populations of adult fibroblastic cells (all Pdgfra+), two
of which were present in the perinatal dataset: Pi16+/Ly6aHi progenitors and
Bace2+/Clec11aHi intermediate cells (Fig. 3.10B). The third fibroblast population was
defined by selective expression of S100a4, which we called “unknown fibroblasts”. In situ
hybridization analysis of Ly6a, Pi16 and Bace2 showed that the spatial localization of
intermediate and progenitor cells was conserved in adults, with intermediate cells located
immediately adjacent to the aortic smooth muscle and progenitors located more distant
radially (Fig. 3.11B,C). Of interest, we did not detect a fibroblastic preadipocyte
(Pparg+/Pdgfra+) population. However, we observed a new cluster of SMCs (SMC 2) that
expressed canonical smooth muscle markers Myh11, Acta2 and Tagln2, along with Pparg
and other adipocyte markers like Lpl and Fabp4 (Fig. 3.10C).
We developed a FACS strategy to purify the following cell types from adult aortas for
bulk RNAseq and functional characterization: (1) intermediate cells (PDGFRa+;CD200+);
(2) progenitors and unknown fibroblasts (PDGFRa+;CD200-); SMC 1 (MCAM+; CD200+);
and SMC-2 (MCAM+;CD200-) (Fig. 3.10D, S5D,E). The expression of cluster-defining
genes from the single cell transcriptomes was mapped onto the sorted cell transcriptomes,
revealing a high level of concordance (Fig. 3.10E, 3.11F,G). We determined cell typedefining gene sets by performing differential gene expression analysis and identifying
genes that were enriched in each cell type compared to all others. This analysis again
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demonstrated that intermediate cells were enriched for components of the “Hedgehog
signaling” pathway while progenitor cells were enriched for the “WNT signaling” pathway
(Fig. 3.10F). SMC-1 cells were enriched for “focal adhesion” and “integrin-mediated cell
adhesion pathways”. Finally, SMC-2 cells were enriched for “Adipogenesis genes”,
“Calcium regulation in the cardiac cell”, and “PPAR signaling (Fig. 3.10F).
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Figure 3.10: Identification of adipogenic smooth muscle cells in adult PVAT. (A)
UMAP projection of clustering of 6,753 cells from adult thoracic aorta of pooled 13-weekold male CD1 mice. (B) UMAP projections showing expression of indicated fibroblast
marker genes. (C) UMAP projections showing expression of indicated smooth muscle cell
marker genes. (D) FACS isolation of fibroblast and smooth muscle cell populations. Live
Lin(-) cells were gated to isolated the following cell populations: Intermediate Cells
[PDGFRa+,MCAM-,CD200+], Progenitors [PDGFRa+,MCAM-,CD200-], Smooth Muscle
Cells-1 (SMC-1) [PDGFRa-,MCAM+,CD200+], SMC-2 [PDGFRa-,MCAM+,CD200-].
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(Representative image of 6 separate experiments). (E) Expression heatmap of Seuratgenerated cluster defining genes mapped on to sorted-cell RNA-Seq results (n=3
biological replicates per group). (F) Pathway analysis of cluster-defining genes for each
cell population. Cluster-defining genes were defined as significantly differentially
expressed genes with log2FC>1.5 in every pairwise comparison (n=3 biological
replicates).
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Figure 3.11: Purification and analysis of aorta-associated cells from adult animals (Related
to Fig. 3.10) (A) Expression dot plot of indicated genes for cell clusters from adult thoracic aorta.
(B) mRNA in situ hybridization of Ly6a (green) in adult thoracic aorta. Arrowhead in inset shows
progenitor cell. DAPI (blue) stains nuclei. (scale bar, 362.3 μm). Lu: aorta lumen. (C) mRNA in situ
hybridization of Pi16 (green) and Bace2 (red). White arrowhead shows progenitor cell. Yellow
arrowhead shows intermediate cell. (scale bar, 145um). (D) FACS isolation of fibroblasts and
smooth muscle cells (SMCs). To exclude debris and isolate single live cells, we gated on: (1) SSCA and FSC-A ; (2) FSC-H vs FSC-W; and (3) SSC-H vs SSC-W. Live (DAPI-); Lin- (CD45-,CD31,Ter119-) cells were then selected. Further selection was then performed to isolate: Intermediate
Cells [PDGFRa+,MCAM-,CD200+], Progenitors [PDGFRa+,MCAM-,CD200-], SMC1 [PDGFRa,MCAM+,CD200+], SMC2 [PDGFRA-,MCAM+,CD200-]. (Representative image of 6 separate
experiments). (E) UMAP projections showing expression of indicated genes used for sorting
strategy. (F,G) Expression heatmap of Seurat- generated cluster-defining genes mapped on to
sorted-cell RNA-Seq results for fibroblast (F) and SMC populations (n=3).
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Adipogenic activity of smooth muscle cells in adult PVAT
We tested the adipogenic differentiation competency of FACS-purified SMC and
fibroblastic populations isolated from peri-aortic adipose tissue of adult mice. CD200+
SMCs (SMC-1) did not undergo adipogenesis, whereas CD200(-) SMCs (SMC-2), which
expressed Pparg and other adipogenic genes, efficiently differentiated into lipid dropletcontaining adipocytes (Fig. 3.12A). The adult fibroblast populations displayed similar
adipogenic activity as their neonatal counterparts, with progenitor cells undergoing robust
adipocyte differentiation, and intermediate cells displaying no adipogenic potential (Fig.
3.12A).
To test if SMCs can contribute to perivascular adipocyte development in adult
animals, we analyzed the aortas of adult Myh11-Cre; tdTomato reporter animals. Under
baseline conditions, tdTomato+ adipocytes were detected, albeit at low levels, in adult
peri-aortic fat. To further investigate the adipogenic activity of SMCs, we treated Myh11Cre; TdTomato reporter mice with rosiglitazone to promote adipocyte turnover (Tang et
al., 2011). Under these conditions, numerous, tdTomato+; PLIN1+ adipocytes were
detected in thoracic PVAT, documenting the adipogenic capacity of SMCs in adult animals
(Fig. 3.12B).
To test if fibroblastic cells are also competent to form adipocytes in adult PVAT, we
tracked the fate of Pdgfra-expressing cells using Pdgfra-CreER; GFP reporter mice (Fig.
3.13A).

These animals were treated with tamoxifen to induce GFP-expression in

fibroblasts, followed by treatment with rosiglitazone. Immunofluorescence analysis
revealed many GFP-marked adipocytes in aortic PVAT, indicating that fibroblastic cells
can participate in de novo adipocyte formation (Fig. 3.13A). RNAseq analyses identified
Gli1 as a selective marker of intermediate cells vs. other fibroblast populations in adult
aorta (Fig. 3.13B). To determine if intermediate cells can generate adipocytes, we
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performed lineage analysis with Gli1-CreERT;GFP mice (Fig. 3.13C). Upon tamoxifen
administration, GFP expression was induced in intermediate fibroblasts lining the aortic
smooth muscle and was not expressed in any adipocytes (Fig. 3.13C). Following
rosiglitazone treatment of Gli1-CreERT; GFP mice, we did not detect GFP+ adipocytes,
suggesting that intermediate cells are not a source of new adipocytes in adult animals
(Fig. 3.13C).
Lastly, we investigated the anatomic localization of the two identified SMC subtypes
in thoracic aortic tissues. Immunostaining for the pan SMC marker TAGLN identified SMC
cells in the adipose tissue proper as well as in the aortic media around the lumen (Fig.
3.12C).

Histologic analysis of the aorta in longitudinal section identified blood vessels

coursing through the adipose tissue (Fig. 3.13D). To determine if the adipogenic
Pparg+/CD200- SMCs (SMC-2) were selectively enriched in the aortic adventitia, we
separated adventitia/adipose tissue and aortic media, and isolated cells for flow cytometry
analysis (Fig. 3.12D). The adventitia was highly enriched for CD200- progenitors and the
cleaned aorta was enriched for CD200+ intermediate cells, verifying the separation
strategy. Notably, there was also striking enrichment of CD200- (adipogenic) SMCs
(SMC-2) in the adventitia samples, whereas the cleaned aorta was enriched for CD200+
SMCs. These data suggest that SMCs within PVAT adopt an adipogenic profile and
capacity in adult animals.
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Figure 3.12: Adipogenic activity of smooth muscle cells in adult PVAT. (A) Cell
populations were sort purified from adult aortas and induced to differentiate into
adipocytes, followed by staining with Bodipy (lipid, green) and Hoechst (nuclei, blue)
Quantification of adipocyte differentiation in cultures (right) (n=3 separate experiments;
mean+/-SEM). (B) Immunostaining of RFP (red), PLIN1 (green), and DAPI (blue) in
sections of thoracic aorta from adult Myh11-Cre-; mTmG and Myh11-Cre+; mTmG mice
treated with vehicle control (DMSO) or rosiglitazone (Rosi). Arrowheads indicate
mTomato-labeled adipocytes from Myh11-Cre+ cells. (n=1 Cre-; n=2 DMSO, n=2 Rosi;
scale bar, 271.8 µm). (C) Immunostaining of TAGLN (red) and DAPI (blue) in sections of
adult thoracic aorta. White arrowheads show adventitial smooth muscle cells. Yellow
arrowhead indicates parenchymal smooth muscle cells of the aorta proper (scale bar,
271.8 µm). (D) Flow cytometry analysis of cell populations in stripped aorta or PVAT alone
from adult CD-1 male mice (n=2 biological replicates of pooled aortas; mean+/-SEM). (E)
Model of thoracic aorta adipose tissue organization. PVAT; Perivascular Adipose Tissue;
Lu; vessel lumen.
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DISCUSSION
Aortic PVAT represents a unique type of thermogenic fat depot that is conserved in
rodents and adult humans. This fat depot exhibits many of the defining properties of
classical BAT, including high levels of UCP1 expression, responsiveness to cold
exposure, dependence on the brown fat transcriptional factor EBF2, and resistance to
obesity-induced inflammation. In this study, we integrated single cell transcriptomics,
genetic fate mapping and in vitro differentiation assays to establish developmental
hierarchies of thermogenic PVAT development and maintenance. We found that
fibroblastic adipocyte progenitors seed the PVAT depot during the late fetal and early
postnatal period. In contrast to conclusions from prior papers, our results suggest that
bona fide SMCs do not significantly contribute to adipocyte formation during the genesis
of PVAT. However, a new population of Pparg-expressing SMCs emerges in adult PVAT
and this SMC subtype undergoes adipocyte differentiation in vitro and in vivo (Fig. 7E).
Aortic brown fat cells rapidly form and become organized into recognizable depots in
the immediate postnatal period between E18 and P3. We hypothesized that this period
would feature large shifts in progenitor cell phenotypes, correlating with the observed burst
of adipogenesis. In actuality, we observed a striking similarity in the stromal cell
composition of the depot immediately prior to birth (when no adipocytes are present) and
after birth (when many adipocytes were present). This finding suggests that perivascular
adipocyte progenitor cells are seeded earlier in development and are poised to undergo
adipocyte differentiation in response to adipogenic cues. The window from E18 to P3
therefore provides a potentially powerful system to identify the signals that control
adipogenesis in vivo.
Cell lineage tracking studies using the SMC-restricted Myh11-Cre driver indicates that
differentiated SMCs do not contribute to aortic PVAT formation during the fetal and early
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postnatal period. This result contrasts with prior studies suggesting that perivascular
adipocytes originate from SMCs, based on lineage tracing studies using Tagln (Sm22)Cre (Chang et al., 2012, Ye et al., 2019). We have confirmed that Tagln-Cre+ cells give
rise to nearly all perivascular structures, including aortic smooth muscle, adventitial
fibroblasts, and adipocytes. We posit that Tagln-Cre is activated during early embryonic
development in a progenitor cell population of undifferentiated cells (i.e. not SMCs) that
do not express Myh11 and are fated for a perivascular, but not necessarily SMC fate.
Consistent with this notion, cells expressing Tagln at E8.5 develop into thermogenic
adipocytes (Ye et al., 2019). Future studies will be needed to define the identity and
developmental trajectories of this upstream early embryonic progenitor cell population.
We identified two distinct groups of adipogenic fibroblasts in fetal and early postnatal
aortas, namely progenitors and preadipocytes. Progenitors were marked by expression of
Pi16 and Dpp4, whereas preadipocytes expressed certain adipocyte-related transcripts,
including the master adipogenic transcription factor Pparg. Notably, analogous
mesenchymal populations, expressing many of the same marker genes, were also
recently identified in subcutaneous WAT (Merrick et al., 2019). In WAT, DPP4+ interstitial
progenitor cells are fibroblasts which reside in the reticular interstitium and give rise to
preadipocytes before finally differentiating into adipocytes (Merrick et al., 2019). Integrated
transcriptomic analyses identified a common gene signature of progenitor cells in PVAT
(i.e. progenitors) and WAT (interstitial progenitors). Pathway analysis identified
enrichment of the anti-adipogenic WNT and TGFb signaling pathways in both PVAT and
WAT progenitors (Kennell and MacDougald, 2005; Longo et al., 2004; MacDougald and
Mandrup, 2002). These pathways presumably play crucial roles in maintaining progenitor
cell identity, at least in part, via suppressing adipogenic progression. We also identified a
common gene signature of PVAT and WAT preadipocytes, which included many genes
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associated with adipogenesis, such as Lpl and Cd36. The common preadipocyte signature
was also significantly enriched for genes linked to cell cycle progression. In this regard,
adipocyte differentiation of preadipocyte cell lines requires a round of post-confluent
mitosis (Tang and Lane, 2012; Tang et al., 2003). However, it remains unclear if the cell
cycle gene profile identified in preadipocytes relates to cell cycle entry, exit or progression.
Interestingly, many genes associated with fatty acid oxidation and mitochondrial
biogenesis were selectively expressed in PVAT (brown) vs. WAT preadipocytes, indicating
that metabolic specialization and divergence is already established in the preadipocyte
state.

Overall, these findings suggest that a conserved adipose cell lineage hierarchy

operates in disparate fat depots, with less committed progenitor cells serving as a
reservoir of preadipocytes.
We identified another interesting fibroblastic cell type in developing and adult aortas,
which we termed intermediate cells due to their anatomic location in between the vascular
smooth muscle cells and adventitial progenitors. Intermediate cells displayed selective
enrichment of Hedgehog signaling genes. Previous studies identified a discrete population
of sonic hedgehog-responsive cells located underneath the aorta, likely corresponding to
intermediate cells

(Passman et al., 2008). These cells did not undergo adipocyte

differentiation either in vitro or in vivo. Understanding the physiologic function of
intermediate cells remains a question of great interest. The intimate association of these
cells with the outer layer of aortic smooth muscle, suggests a potential role in modulating
vascular biology. In this regard, a recent report suggests that fibroblastic cells surrounding
the vasculature have the capacity to differentiate into SMCs in the setting of dramatic
vessel injury (Tang et al., 2020). Future work will determine if intermediate cells and/or
other fibroblast subtypes adopt different phenotypes in pathologic states such as during
atherogenesis or aneurysm development.
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Our results suggest that adult PVAT does not retain a classical preadipocyte cell
population, considered to be fibroblastic cells (i.e. Pdgfra+) that express adipogenic genes
like Pparg. This result was surprising to us given that fibroblastic preadipocyte populations
have been identified by us and others across several WAT depots. Rather, we found that
adult PVAT contained a distinctive subset of SMCs that selectively expressed Pparg and
other adipocyte-related genes. These Pparg+ SMCs clustered together with another SMC
population, with both groups expressing similarly high levels of canonical SMC marker
genes, including Myh11. Importantly, the Pparg+ SMC population displays robust potential
to differentiate into adipocytes. Adult PVAT also contains progenitor cells, a fibroblast
population with the potential to produce adipocytes. Our study suggests that both SMCs
and progenitor cells contribute to the maintenance of adult PVAT. An elegant study by the
Graff group revealed the existence of distinct lineages of embryonic and adult adipocyte
progenitors in WAT (Jiang et al., 2014). Intriguingly, they found that adult adipocyte
progenitors in WAT arise via an Acta2-expressing mural or SMC. It remains unclear if
these Acta2+ cells in WAT or SMC in PVAT progress through a fibroblastic intermediate
(i.e. preadipocyte) or differentiate directly into adipocytes. Another outstanding question
is whether these different types of adipocyte progenitors in WAT and BAT/PVAT depots
have the potential to differentiate into both white and brown or beige adipocytes.
In summary, this work defines the progenitor cells responsible for the development
and maintenance of PVAT, a distinct thermogenic depot conserved in rodents and
humans. A fibroblastic lineage, consisting of progenitor cells and preadipocytes, mediates
the initial formation of aortic PVAT. After the postnatal period, this fat depot acquires an
adipogenic subpopulation of SMCs. In adults, the aortic PVAT possesses two apparently
independent sources of new adipocytes: adipogenic SMCs and fibroblastic progenitor
cells. Additionally, a distinct fibroblast subtype is intimately associated with the aortic
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SMCs and does not contribute to adipocyte development or maintenance. The
identification of the native progenitors for thermogenic adipocytes provides a critical
framework for further investigations aimed at developing brown fat targeted therapeutics.

95

CHAPTER 4: DISCUSSION AND FUTURE DIRECTIONS
SUMMARY
My thesis work sought to identify principles governing the differentiation and
transcriptional control of thermogenic adipocytes. The motivation for these studies is the
observation that increasing brown adipose tissue mass and activity could serve as a
potential obesity therapy (Yoneshiro et al., 2013). Understanding factors that control the
ability of brown adipocytes to maintain expression of the thermogenic program, that is the
ability of adipocytes to exhibit sympathetic-stimulated uncoupled respiration, motivated
studies identifying a novel role for EBF activity in regulating adaptive cold responses
through ERR/PGC1a. In this study, we identified that adipocyte-EBF2 is required for basal
BAT thermogenic character and adrenergic-stimulated in vivo thermogenesis. Notably,
adrenergic stimulation facilitated re-expression of thermogenic genes in Ebf2 mutant mice,
which led us to identify that EBF1 compensates for the loss of Ebf2 in cold exposed mice.
We utilized transcription factor reporter assays and in vivo transcriptomic analysis to
identify that EBF activity promotes ERRa and PGC1a activity and expression in brown
adipocytes. These studies highlighted an important role for a traditionally developmental
transcriptional regulator of thermogenesis in controlling adaptive thermogenic gene
transcription.
In complementary studies, we sought to determine the precise developmental and
maintenance structure of PVAT, a thermogenic adipose depot that is present in humans
(Cypess et al., 2013, 2015). We identified that perivascular adipose tissue develops
postnatally in mice from a pool of seeded progenitor cells prior to E18. Upon birth,
fibroblastic progenitor and preadipocyte cells differentiate into mature thermogenic
adipocytes. Interestingly, the lineage relationship between progenitor and preadipocyte
cells bears strikingly resemblance to the lineage hierarchy in subcutaneous white adipose
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tissue (Merrick et al., 2019). In adult mice, we were unable to identify a fibroblastic
preadipocyte, but rather discovered a novel adipogenic smooth muscle cell population in
the adventitia that has the capacity to make adipocytes in vitro and in vivo. Taken together,
these two studies have shed light on the pathways that control and the cells that become
thermogenic adipocytes in vivo.
FUTURE DIRECTIONS
Transcriptional control of thermogenic adipocytes
Identification of factors that control the development and maximum activation of
thermogenic adipose tissue is a priority for leveraging the therapeutic use of these tissues
in humans. Notably, few factors have been implicated as master regulators of both
adipocyte development and environmental responsiveness. In our study, we established
that EBF activity controls basal and adaptive thermogenic gene transcription in brown
adipocytes. We identified that chronic cold exposure can facilitate re-expression of
thermogenic genes in Ebf2 mutant BAT. Interestingly, reacclimation of mice to room
temperature for just one week following cold exposure led Ebf2 mutant BAT to adopt a
whitened transcriptional program. This result suggests that chronic adrenergic signaling
promotes Ebf2 independent thermogenic gene expression. Notably, we know quite little
about the factors responsible controlling the chronic-cold exposure response. Much of the
work performed studying the adrenergic response, has traditionally used cell systems with
acute administration of sympathetic agonists (Cao et al., 2001, 2004). Notably, cold
exposure elicits a systemic response, of which one component is increased betaadrenergic signaling (Cannon and Nedergaard, 2004). Understanding what the precise
factors are that maintain this increased thermogenic gene transcription during chronic cold
exposure and how they differ from acute systems remains an area of active investigation.
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We identified Ebf2 mutant mice weigh the same as their littermate controls in spite
of loss of thermogenic gene expression in adipocytes. This observation has been
observed by other groups studying the influence of thermogenic gene expression in
regulating energy balance (Emmett et al., 2017; Harms et al., 2014). While ectopic
expression of thermogenic regulators in white fat suppresses metabolic disease, loss of
thermogenic gene expression is not sufficient to impair energy balance (Seale et al., 2011;
Stine et al., 2016). Understanding how loss of thermogenic gene expression in adipocytes
controls the response of other organs to high-fat diet remains an area of future study.
Whether loss of thermogenic gene transcription in adipocytes increases energy
expenditure in other metabolic organs such as muscle remains to be determined.
Interestingly, there appears to be important feedback regulation between BAT activity and
the brain controlling food intake (Li et al., 2018). Determining if these pathways are
perturbed in mice without thermogenic adipose tissue on high fat diet would shed light on
these processes.
There exists great controversy as to whether beige adipocytes developing under
cold exposure are the same as brown adipocytes in cold-exposed BAT. The Rosen group
utilized a novel nuclear purification protocol to identify that the epigenome of cold exposed
brown and beige adipocytes are very similar (Roh et al., 2018). While these adipocytes
may display the same enhancer landscape following cold exposure, our observation that
Ebf2 is required for cold-induced beige adipogenesis, but dispensable for the chronic cold
response in brown fat suggests the factors controlling these processes are distinct.
Whether there is differential reliance on Ebf2 for the adipocytes and progenitors present
in the tissue to transdifferentiate or de novo differentiate into beige adipocytes is unknown.
Generating mouse models where Ebf2 can be specifically deleted in progenitor cells or
adipocytes would facilitate determining whether Ebf2 is required for one of these particular
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processes. Elucidating the differences between beige and brown adipose tissue
responsiveness to cold exposure would refine our understanding of how heterogenous
pools of adipocytes and progenitor cells respond to a complex environmental perturbation
such as cold exposure.
We identified that EBF1 compensates for the loss of Ebf2 in promoting
thermogenic gene transcription in cold-exposed mice. Furthermore, both factors were
capable of cooperating with PGC1a in transcription factor reporter assays. However,
deletion of Ebf2 alone in adipocytes revealed a dramatic defect in thermogenic gene
expression, while deletion of Ebf1 in adipocytes had minor effects on the thermogenic
program. Whether total EBF activity is important for thermogenic gene transcription or
particular EBFs play distinct roles in developmental versus adaptive thermogenic gene
transcription remains to be determined. Important to answering these questions would
involve identifying the relative levels and cistromes of EBF1 and EBF2 in basal and coldexposed BAT. Generation of epitope-tagged mice using Crispr Cas9 technology would
allow the same antibodies for immunoblotting and immunoprecipitation and facilitate
interpretation in comparable experimental systems. Our group has previously identified
that EBF2 interacts with the BAF chromatin remodeling complex to promote PPARg
activity during brown adipogenesis. Notably, a group identified that a member of the BAF
chromatin remodeling complex is recruited to thermogenic gene enhancers upon betaadrenergic stimulation (Abe et al., 2015). Whether EBF1 performs these functions as well
and whether cold changes these activities is unknown.
Determining how factors important for the differentiation of thermogenic adipocytes
control adipogenesis remains an area of outstanding study. Data from our group suggests
that ectopic expression of Ebf2 in non adipogenic C2C12 myoblasts is sufficient to
promote sensitization to adipogenic cocktail and adipogenesis (Rajakumari et al., 2013).
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Important in these studies is that Ebf2 expression is not sufficient to promote adipogenesis
in the absence of adipogenic cocktail. Similar observations were made with the ability of
PRDM16 to promote thermogenic adipocyte differentiation in C2C12s through binding with
CEBP/b (Kajimura et al., 2009; Seale et al., 2008). Whether EBF2 binds CEBPs or other
factors important for adipogenesis is unknown. Furthermore, the differences in where
EBF2 binds in C2C12s prior to cocktail administration, immediately following induction and
in mature adipocytes has not been determined. It is known that while EBF2 binds at
enhancers near many brown adipocyte-specific genes in mature brown adipocytes,
whether it binds to a subset of these sites or different sites completely prior to adipogenic
cocktail remains an area of active inquiry.
Identifying the factors that control expression of important thermogenic regulators
of adipogenesis remains a great unanswered question in the field of adipose biology. One
important question that remains to be resolved is: What turns on Ebf2 in the brown adipose
lineage? Understanding the pathways that turn on Ebf2 expression and activity in brown
adipocytes may provide novel mechanisms for inducing thermogenic gene expression in
white adipose tissue. Previous work from our lab has identified that Ebf2 is expressed in
fibroblastic brown preadipocytes at E14 (Wang et al., 2014). Notably, EBF2 promotes a
brown as opposed to adipogenic phenotype in these cells, given Ebf2- fibroblastic cells
become white adipocytes ex vivo and Ebf2 mutant mice develop white adipose tissue in
vivo (Rajakumari et al., 2013; Wang et al., 2014). A variety of targeted and high throughput
methods can be used to identify what factors or pathways promote Ebf2 expression in
brown preadipocytes. A targeted approach would involve utilizing single cell RNA
Sequencing during embryogenesis to identifying the cells that first express Ebf2. Isolation
of these cells and their immediate upstream progenitor would facilitate ATAC-seq studies
to determine what genomic regions near Ebf2 become accessible upon Ebf2 expression
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and what transcription factor binding motifs are enriched in those putative enhancers.
Crispr-mediated deletion of the enhancers could identify enhancers required for Ebf2
expression in brown adipocytes. In parallel studies, identifying what signaling pathways
control this differentiation using pseudotemporal analysis could inform what factors to
prioritize for CHIP and functional analysis. In an unbiased fashion, one could develop a
fluorescent reporter of Ebf2 expression and use pooled Crispr-knockout or activation
screens to determine what genes promote or suppress Ebf2 expression. Taken together,
these sets of experiments could provide important insight into the pathways controlling the
expression of a key regulator of thermogenesis.
Development of thermogenic adipocytes
Understanding the precise identity of adipogenic progenitor cells in thermogenic
adipose tissue could provide important insight into how augment thermogenic adipose
tissue mass in vivo. While much of the studies on rodent thermogenic adipose tissue
development focus on interscapular BAT, this depot is not present in adult humans (Lidell
et al., 2013). Notably, humans have depots of thermogenic adipose tissue located in the
supraclavicular region and around large blood vessels (Cypess et al., 2013). Prior to our
study, little was known about the precise developmental hierarchy of this thermogenic
adipose depot. We identified that perivascular adipose tissue develops from a pool of
seeded progenitor cells at embryonic day 18 (E18) into an adipose depot as soon as postnatal day 3 (P3). We determined that the fibroblastic cells we called progenitors and
preadipocytes are responsible for the initial development of thermogenic PVAT using cellbased differentiation assays and in vivo lineage tracing. Furthermore, we identified a
conserved lineage hierarchy amongst PVAT progenitors and preadipocytes when
compared to subcutaneous WAT progenitors and preadipocytes. Analysis of adult thoracic
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PVAT did not identify a fibroblastic preadipocyte, but rather a smooth muscle cell that
expressed many adipogenic genes. This adventitial smooth muscle population had the
capacity to generate adipocytes in vitro and in vivo. Taken together these experiments
provided important insight into how thermogenic PVAT develops and is maintained. These
studies will serve as an important foundation for future work identifying the physiologic
importance of thermogenic PVAT and highlighting the importance of heterogenous stromal
populations in pathologic conditions.
One surprising observation from this work was the striking similarity between the
composition of thermogenic PVAT at E18 and P3. We initially chose these timepoints
since we saw no adipocytes at the embryonic time point and robust adipocyte
development during the postnatal period. We hypothesized that a new population of
adipogenic fibroblasts would arise during this period and be responsible for this wave of
adipogenesis. Interestingly, there was little shift in population structure when comparing
these adipose depots. This suggests to us that the adipogenic fibroblastic populations
seed the perivascular adipose depot and wait for differentiation signals following birth.
This observation raises two important areas of future inquiry: the first is what is the
nature of the differentiation signal following birth and the second is where do these
adipogenic fibroblasts come from during embryogenesis. Since the adipogenic cell types
composing PVAT are similar at E18 and P3, there must be some signaling event that
either promotes adipogenesis during the postnatal period or suppresses adipogenesis
during the embryonic period. Determining whether E18-derived stromal cells are as
adipogenic in culture as their P3 counterparts would determine whether adipogenic
competency is licensed during embryogenesis. Interestingly, comparative transcriptomic
analysis of the adipogenic fibroblasts: progenitors and preadipocytes at E18 and P3 could
reveal signaling pathways that are specifically altered following birth. One hypothesis
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could be that the exposure to maternal milk increases energy delivery to the fetus and that
promotes adipogenesis. Understanding how nutrients from mother to fetus promote
adipogenesis would reveal key insights into how the environment controls differentiation
of primed progenitor cells. The other interesting conclusion this experiment raises is that
E18 thoracic PVAT is seeded with adipogenic progenitor cells at an earlier embryonic
timepoint. Descending aortic smooth muscle cells are derived from a mesodermal lineage,
but we know that these smooth muscle cells do not develop into thermogenic adipocytes
in the perinatal period (Wasteson et al., 2008). Whether there is another population of
cells that migrates into the perivascular compartment during embryogenesis to produce
these cells remains an area of outstanding inquiry. Furthermore, the precise identity of
these upstream progenitors are remains unknown. Analysis of our Penk-Cre reporter mice
at timepoints starting at and prior to E18 may provide insight into when this adipogenic
population is specified.
Further studies identified a conserved lineage relationship between the adipogenic
fibroblastic progenitor and preadipocyte cells in PVAT and subcutaneous WAT. We
identified preadipocyte cells as cells that clustered closely to adipocytes and were notable
for increased expression of genes involved in adipogenesis including Pparg and Lpl.
Progenitor cells expressed genes involved in Wnt and Tgf-beta signaling as well as Pi16
and Dpp4. Our group had previously identified a lineage hierarchy in subcutaneous white
adipose tissue of Dpp4+ progenitor cells having the capacity in transplant studies to
generate preadipocyte cells in vivo (Merrick et al., 2019). We demonstrated that
fibroblastic progenitors and preadipocytes from thoracic PVAT were committed to the
thermogenic adipocyte lineage ex vivo, in comparison to preadipocytes isolated from
subcutaneous WAT. We sought to determine whether we could identify shared gene
programs involved in regulating adipocyte progenitor maturation by comparing
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transcriptomes from progenitor and preadipocyte cells in thoracic PVAT and
subcutaneous WAT at P3. We identified a common gene signature enriched in progenitor
cells notable for expression of prostaglandins, Wnts and Tgf beta targets. Reassuringly,
our group had previously identified a role for Tgf-beta signaling in controlling progenitor
state in subcutaneous WAT (Merrick et al., 2019). Interestingly, these data suggest
suppression of prostaglandin signaling may be important in the progenitor to preadipocyte
transition. Drugs modulating prostaglandin signaling are widely prescribed and whether
they control cell fate decisions in adipogenic progenitors remains to be determined
(Ricciotti and FitzGerald, 2011).
Analysis of the common gene signature enriched in preadipocyte cells revealed
the expected enrichment of genes involved in adipogenesis and Ppar signaling,
highlighting their proregression towards becoming an adipocyte. Notably, this group of
genes was also enriched for genes involved in cell cycle progression and cell division. It
has been identified that immortalized fibroblastic cells undergo cell division in the
adipogenic progression (MacDougald and Mandrup, 2002; Tang et al., 2003). Whether
this gene signature is of cells entering or exiting the cell cycle remains to be determined.
Future studies will be required to identify whether this proliferation is required for lineage
progression in vivo. Examination of the genes that are induced in preadipocytes
exclusively in thermogenic PVAT revealed dramatic enrichment for genes involved in fatty
acid oxidation and oxidative metabolism as well as transcriptional regulators of
mitochondrial biogenesis. This observation suggests that thermogenic preadipocytes are
already acquiring the hallmarks of thermogenic adipocytes in this precursor state. Whether
these cells exhibit differential metabolism when compared to their white preadipocyte
counterparts remains to be determined. Taken together, these experiments highlight the
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shared and unique properties of adipogenic progenitor cells isolated from distinct anatomic
compartments.
While the focus of this first paper was centered on the adipogenic progenitor and
preadipocyte cells, we also identified a population of non-adipogenic fibroblasts in adult
developing PVAT we called intermediate cells. These fibroblastic cells were notable for
their expression of hedgehog target genes including Gli1 as well as their distinct anatomic
location, in close proximity to the aortic smooth muscle cells. Interestingly, another group
has identified a population of fibroblastic cells that responded to hedgehog signaling
located underneath the aorta (Passman et al., 2008). While these fibroblastic cells do not
become adipocytes themselves, whether there exists crosstalk between these cells and
the progenitors located nearby remains to be determined. Furthermore, given their close
proximity to the vessel lumen, these cells may play important roles in vascular physiology
or pathology. One group suggested a fibroblastic population underneath the mouse aorta
serves as a reservoir for progenitor cells following dramatic injury, whether these cells are
intermediate cells or progenitor cells remains to be determined (Tang et al., 2020). It is
tempting to think that signaling from these intermediate cells controls smooth muscle
physiology. Mining our single-cell data for receptor-ligand interactions may reveal novel
pathways that are regulated between the two cell types (Shao et al., 2020). Furthermore,
whether these cells have the capacity to influence pathologic processes such as
atherogenesis or aneurysm generation remains to be determined. Notably, much of the
atherosclerotic lesion is thought to develop from a Myh11+ cell, but whether this cell fate
transition is controlled by intermediate cells has yet to be determined (Misra et al., 2018;
Shankman et al., 2015).
We identified a novel population of adipogenic smooth muscle cells located within
the aortic adventitia. These smooth muscle cells are notable for their expression smooth
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muscle defining genes including Myh11 and Tagln as well as genes associated with
adipogenesis including Pparg and Lpl. Enrichment analysis of flow sorted aortas revealed
enrichment of this adipogenic population in the adventitia of mouse aortas. One
outstanding question is where these adipogenic smooth muscle cells come from. While,
they do not appear to be a prominent population in the perinatal dataset, they represent a
substantial portion of the smooth muscle cells in adult PVAT. Determining when these
cells arise during mouse development and what factors control this process remain
outstanding lines of inquiry. Whether these cells develop directly from fibroblastic cells
specified in the postnatal period or arise from pre-existing smooth muscle cells could be
identified using pulse-chase lineage tracing experiments in vivo. In addition to where these
adipogenic smooth muscle cells come from, we identified that they have the capacity to
make adipocytes in vivo. What environmental factors such as cold exposure or high fat
diet control this cell fate decision remain outstanding questions as well as the relative
importance of this adipogenic smooth muscle population versus the fibroblastic progenitor
population in generating new adipocytes in adult PVAT remains unknown.
One of the motivating factors driving our interest in thermogenic PVAT was its
unique anatomic location, in close proximity to large blood vessels. Whether this
thermogenic adipose depot has any unique function in controlling cold-exposure
physiology or vascular pathology remains to be determined. Notably, this study defined
the constituent cell types of developing and adult PVAT which will facilitate further studies
determining whether particular fibroblastic or smooth muscle compartments have distinct
roles in controlling pathologic situations such as atherogenesis or aneurysm development.
Furthermore, our studies have shed light on the precise developmental origin of
thermogenic PVAT, which will enable us to design specific Cre drivers for temporal control
of PVAT thermogenic character. We have demonstrated that deletion of Ebf2 in
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adipocytes is sufficient to lead to dramatic loss of thermogenic gene expression in PVAT;
however, this model deletes Ebf2 in all adipocytes. Notably, generating a Penk-CreER
mouse would also lead to deletion of Ebf2 in Penk+ neuronal populations so utilization of
a split-Cre system would likely result in the most temporal and spatial specificity for future
studies determining a role for the thermogenic character of this adipose tissue in
controlling physiologic and pathologic responses (Meador et al., 2019; Tasic et al., 2018;
Wang et al., 2012).
One of the main goals of studying the development of thermogenic adipose tissue
is to inform strategies that seek to increase thermogenic adipose tissue mass in humans.
Notably, there have been two main strategies to approach this: one focuses on the
browning of adipocytes in humans using pharmacologic agents and the other relies on a
cell-therapy based approach where cells are harvested from a patient, differentiated into
thermogenic adipocyte ex vivo and reimplanted (Tseng et al., 2010). These cell-based
approaches either rely on the isolation, expansion, and differentiation of thermogenic
adipocyte-progenitor cells or generation of induced pluripotent stem cells from somatic
cells that can be differentiated down any lineage (Tseng et al., 2010). Identification of
thermogenic adipocyte progenitor cells in humans remains a priority for future work.
Whether human thermogenic adipocyte progenitors have the identity of adipogenic
smooth muscle cells or fibroblastic progenitor cells identified in the mouse aorta remains
to be determined. Experiments understanding the precise developmental hierarchy of the
fibroblastic embryonic perivascular adipocyte progenitors

may

inform directed

differentiation strategies that seek to make induced-pluripotent thermogenic adipocyte
progenitors. One group generating thermogenic adipocytes utilized a strategy that
generated FOXF1+ splanchnic mesoderm to generated a “mural” stem cell intermediate
that was notable for expression of Cd146, which is highly expressed on SMCs (Su et al.,
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2018). Whether these cells resemble the adipogenic smooth muscle cells in adult mice
remains an outstanding question. Taken together, this work has identified key
transcriptional regulators and developmental stages of thermogenic adipocyte
development and function. These studies will inform future work focused on maximizing
the thermogenic identity of brown adipocytes by identifying their in vivo progenitors and
the key molecules required for thermogenic competency.
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CHAPTER 5: MATERIALS AND METHODS
Corresponding to Chapter 2: Early B Cell Factor activity controls developmental and
adaptive thermogenic gene programing in adipocytes.
Adapted from: Angueira AR, Shapira SN, Ishibashi J, Sampat S, Sostre-Colón J, Emmett
MJ, Titchenell PM, Lazar MA, Lim HW, and Seale P. Early B Cell Factor Activity Controls
Developmental and Adaptive Thermogenic Gene Programming in Adipocytes. Cell
Reports. 2020; 30(9), 2869-2878. PMID: 32130892.
Key Resources Table:
REAGENT or RESOURCE
Antibodies

SOURCE

IDENTIFIER

Rb anti Histone H3 (acetyl K27)
Ms anti Human/Mouse UCP1
Ms anti Alpha tubulin
Ms anti Total Oxphos Rodent Antibody Cocktail
Anti-rabbit IgG IRDye 800CW
Anti-mouse IgG IRDye 800CW

Abcam
R&D
Sigma
Abcam
Li-Cor
Li-Cor

RRID:AB_2118291
RRID: AB_10572490
RRID:AB_477583
RRID:AB_2629281
RRID:AB_621848
RRID:AB_621847

Chemicals, Peptides, and Recombinant Proteins
BCS
Hepes 1M
16% Paraformaldehyde

ATCC
Thermo Fisher
EMS

Cat#30-2030
Cat#15630080
Cat#15710

Protein-A Sepharose CL-4B Beads

GE Healthcare

Cat#17-0780-01

PCR Master Mix, Power SYBR Green

Applied
Biosystems
Invitrogen

Cat#4367659

NEBNext Ultra II DNA Library Prep with Sample
Purification Beads
NEB Next Ultra RNA Library Prep Kit

NEB

Cat#E7103

NEB

Cat#E7530

DMEM

MediaTech

Cat#MT10-017-CV

Dispase II

Roche

Cat#4942078001

Collagenase D

Roche

Cat# 11088882001

TRIzol

Invitrogen

Cat#15596018

Purelink RNA Mini columns

Invitrogen

Cat#LT-12183018

ABI High-Capacity cDNA Synthesis kit

Cat#4368813

FluoroBrite DMEM

Applied
Biosystems
Thermo Fisher

CL-316,243

Sigma Aldrich

Cat#C5976

Free Glycerol Reagent

Sigma Aldrich

Cat#F6428

Bovine Serum Albumin, Fraction V, Fatty Acid
Free
Pierce BCA Protein Assay

Roche

Cat#03117057001

Thermo Fischer

Cat#23225

Lipofectamine 2000
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Cat#11668027

Cat# A1896701

Deposited Data
RNA sequencing data
H3K27Ac ChIP Sequencing data

GEO repository
GEO repository

GSE
GSE

The Jackson
Laboratory
Dr. Patrick Seale
Dr. Rudolph
Grosschedl

RRID:IMSR_JAX:0108
03

Experimental Models: Organisms/Strains
Adipoq-Cre
Ebf2 fl/fl
Ebf1 fl/fl
Recombinant DNA
pcDNA-PGC1a, and pcDNA-ERRa
pcDNA-EBF2, pcDNA-EBF1, pcDNA-EBF2,
pcDNA-EBF3, pcDNA-PPARg, pGL4-Ucp1 -6, and
pcDNA-RXRa
lentiCRISPR v2

Dr. Mitchell Lazar
Dr. Patrick Seale
Addgene (F.
Zhang)
Addgene (D.
Trono)
Addgene (D.
Trono)

RRID:Addgene_52961

Graphpad
(https://www.grap
hpad.com/scientif
icsoftware/prism/)
UCSC
(http://genome.uc
sc.edu/)

RRID:SCR_002798

https://software.b
roadinstitute.org/
morpheus/
http://homer.ucsd
.edu/

RRID:SCR_017386

Star Aligner

https://github.com
/alexdobin/STAR

RRID:SCR_015899

ToppGene

http://toppgene.c
chmc.org/

RRID:SCR_005726

pMD2.G
psPAX2

Software and Algorithms
GraphPad Prism 7

UCSC Genome Browser

Morpheus (Heat Maps) by the Broad Institute
Homer

EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
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RRID:Addgene_12259
RRID:Addgene_12260

RRID:SCR_005780

RRID:SCR_010881

Mice were housed under the care of University of Pennsylvania University
Laboratory Animal Resources (ULAR), which provides both basic husbandry and
veterinary care. Animals were raised at room temperature on standard chow with
a 12-hour light/dark cycle. The following strains were obtained from the Jackson
Laboratory:

AdipoqCre

(strain

name:

B6

B6;FVB-Tg(Adipoq-cre)1Evdr/J,

RRID:IMSR_JAX:010803) (Eguchi et al., 2011). The following stock was
generated by Patrick Seale: Ebf2 loxP/loxP (Shapira et al., 2017). The following
stock was generated by Rudolph Grosschedl: Ebf1 loxP/loxP (Györy et al., 2012).
Experiments performed at P0.5 and embryonic time points were conducted on
male and female mice. Experiments at adult time points were performed in male
mice between the ages of 8 to 12 weeks at the onset of the experiment. All mouse
housing and husbandry occurred at RT (22°C) unless specified otherwise. For
chronic cold exposure, 8- to 10-week-old mice were pair-housed in cages at 4°C.
For thermoneutral acclimation, 4- to 5-week old mice were housed at 30°C for one
month.

METHOD DETAILS
Thermogenic Capacity Assays and Metabolic Phenotyping
For thermogenic capacity assays, CLAMS metabolic chambers (Columbus
Instruments) were warmed to 33°C. Mice were placed in chambers and sedated
with 75 mg/kg Nembutal. Following 1 round of reading (13 minutes), mice were
injected with 1 mg/kg NE (Sigma A9512-1G) subnuchally and VO2 was measured
until mice woke up (Kissig et al., 2017). For basal metabolic phenotyping, mice
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were placed into CLAMS metabolic chambers warmed to 30°C. Average hourly
light/dark oxygen consumption and RER measurements were obtained using CalR software (Mina et al., 2018). 45% HFD was obtained from Research Diets
[D12451].

Cold Tolerance Tests
8- to 10-week-old room temperature acclimated mice were singly housed in prechilled cages at 4°C, with rectal temperatures measured hourly for 6 hours.

Body Composition Analysis
Body weight and body composition were measured in ad-lib fed conscious mice
using EchoMRI™ 3-in-1 system nuclear magnetic resonance spectrometer (Echo
Medical Systems, Houston, TX) to determine whole body lean and fat mass.

Lipolysis Assay
Fresh eWAT depots were dissected from ad libitum-fed mice and put into
FluoroBrite DMEM. The depots were then cut into 4-6 small similar-sized pieces
and transferred into 150 µL FluoroBrite DMEM supplemented with 2% FA-free BSA
in 96-well plates for 30 min for pre-incubation. To analyze basal lipolysis, tissues
were transferred into 150 µL of fresh FluoroBrite DMEM supplemented with 2%
FA-free BSA for 60 min. Then, the tissues were transferred and pre-incubated for
30 min in 150 µL FluoroBrite DMEM supplemented with 2% FA-free BSA in the
presence of 10 µM CL 316,243. To analyze stimulated lipolysis, tissues were
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transferred into 150 µL fresh FluoroBrite DMEM supplemented with 2% FA-free
BSA and 10 µM of CL 316,243 for another 60 min. Glycerol content was analyzed
by combining 5 µL of supernatant and 200 µL of Free Glycerol Reagent and
incubating for 15 min at room temperature before measuring absorbance at 540
nm. At the end of the experiment, the tissue pieces were delipidated by CHCL3
extraction and solubilized in 0.3 N NaOH/0.1% SDS at 65°C overnight. Protein
content was determined using Pierce BCA Protein assay. Results are expressed
as µmol of glycerol per mg of tissue protein.

Isolation of stromal vascular fraction (SVF) from brown adipose tissue (BAT)
BAT SVF was isolated as previously described (Rajakumari et al., 2013). Briefly,
BAT was minced and placed into digestion medium (DMEM, Collagenase D:
6.1mg/ml (Roche), Dispase II: 2.4 mg/ml (Roche) and placed at 37°C with constant
agitation at 200 rpm for 45 min. Cells were filtered through a 100 µm filter into an
equal volume of complete medium (DMEM/10% FBS). Cells were pelleted at 400g
for 4 min.

Histology
Tissues were fixed in 4% PFA overnight, washed in PBS, dehydrated in ethanol,
paraffin-embedded and sectioned. Sections were stained with hematoxylin and
eosin. Images were captured on a Keyence inverted microscope. For transmission
electron

microscopy,

BAT

was

fixed

in

2.5%

glutaraldehyde,

2.0%

paraformaldehyde in 0.1 M sodium cacodylate buffer (pH 7.4) overnight at 4°C.
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Thin sections were stained with uranyl acetate and lead citrate and analyzed with
a JEOL 1010 electron microscope.

RNA Extraction, qRT-PCR, and RNA-sequencing analyses
Total RNA was extracted from using TRIzol (Invitrogen) combined with Purelink
RNA columns (Fisher) and quantified using a Nanodrop. mRNA was reverse
transcribed into cDNA using the ABI High-Capacity cDNA Synthesis kit (ABI).
Real-time PCR was performed on an ABI7900HT PCR machine using SYBR green
fluorescent dye (Applied Biosystems). Fold changes were calculated using the
DDCT method, with Tata Binding Protein (Tbp) mRNA serving as a normalization
control. RNAseq libraries were prepared using the NEB Next Ultra RNA Library
Prep Kit and sequenced on a NovaSeq 6000 (PE150) (Novogene). RNA-seq reads
were aligned to UCSC mm9 genome using STAR aligner with an option, “-outSAMstrandField intronMotif

--outFilterMultimapNmax 1” (Dobin et al., 2013).

Mitochondrial reads were filtered out to avoid sequencing depth bias due to
mitochondrial abundance. Then, reads aligned to genes were counted using
featureCounts (Liao et al., 2014). Differential gene expression analysis was
performed using edgeR (Robinson et al., 2010). Hierarchical clustering was
performed to identify distinct functional modules of genes using Ward’s criterion
and Pearson correlation as a similarity measure. Gene ontology analysis was done
using EnrichR (Chen et al., 2013).

Chromatin Immunoprecipitation (ChIP) and ChIP-Sequencing Analysis
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ChIP analysis was performed as previously described (Emmett et al., 2017).
Briefly, frozen BAT was thawed and minced in 1% formaldehyde for 20 min at room
temperature and quenched with the addition of 2.5 M glycine. BAT was sonicated
in (50 mM HEPES pH 7.5, 155 mM NaCl, 1 mM EDTA, 1.1% Triton X-100, 0.11%
Sodium-deoxycholate, 0.1% SDS) using probe sonication (30 sec on 30 sec off, 3
times at amplitude 10, then 30 sec on 30 sec off, 3 times at amplitude 15) at 4°C
(Fischer Scientific, FB705 Sonic Dismembrator). Primary antibodies were added
for overnight incubation at 4°C with rotation. Primary antibody used was 1 µg per
sample anti-histone H3K27Ac (ab4729). Protein A Sepharose beads (GE
healthcare) were then added for 4 hours at 4°C. Samples were washed twice with
sonication buffer (50 mM HEPES pH7.5, 155 mM NaCl, 1 mM EDTA, 1.1% Triton
X-100, 0.11% Sodium-deoxycholate, 0.1% SDS), once with sonication buffer with
500mM NaCL, once with wash buffer (10 mM Tris-HCl pH 8.0, 250 mM LiCl, 0.5%
NP-40, 0.5% Sodium-deoxycholate, 1 mM EDTA), and twice with TE (1 mM EDTA,
20 mM Tris at pH 8). Samples were then eluted from beads with warm 100 mM
NaHCO3/1% SDS buffer. Samples were reverse cross-linked overnight at 65°C
with RNase A and then treated with proteinase K and column purified (Clontech
NucleoSpin). Libraries were prepared using the NEB Next Ultra DNA Library Prep
Kit and sequenced on a Illumina Hiseq 4000 (PE150) (Novogene). ChIPsequencing reads were aligned to UCSC mm9 genome using STAR aligner with
an option, “--alignSJDBoverhangMin 999 --alignIntronMax 1 --alignMatesGapMax
2000

--outFilterMultimapNmax

1

--alignEndsType

EndToEnd

--

outFilterMismatchNoverLmax 0.05”. Before downstream analysis, aligned read115

pairs were down-sampled to 1/3 for each sample. H3K27ac peaks were called
using “findPeaks” in Homer with an option, “-nfr -tbp 0”. Specifically, “-nfr” option
was used to center peaks at nucleosome free regions as a putative transcription
factor binding sites (Heinz et al., 2010). All the genomics regions of 200 bp around
the peak centers were pooled, merged, and resized to 200 bp to prepare a master
enhancer set as an anchor for comparative analysis. Then, H3K27ac tag counts
were measured in these regions across all the samples. Differential analysis was
done using edgeR to identify genotype or environment-dependent enhancers. De
novo motif search was performed using Homer to predict potential transcription
factors that are responsible for the enhancer regulation.

Western blotting
Adipose tissue samples were homogenized in RIPA (50mM Tris HCl, 150 mM
NaCl, 1% NP-40, 0.5% Sodium deoxycholate, 0.1% SDS) in a TissueLyser
(Qiagen) at 4°C. Samples were separated on 4-12% Bis-Tris NuPage gels
(Invitrogen) and transferred to nitrocellulose membranes for Western blot analysis
on Odyssey Licor Machine. Primary antibodies used were anti-UCP1 (1:1000;
R&D Systems, MAB6158), anti-TUBULIN (1:5000; Sigma, DM1A), and totalrodent OXPHOS antibody cocktail (1:5000; Abcam, 110143).

Cell Culture & Transcription Assays
NIH 3T3 cells (ATCC) were grown in 10% BCS/DMEM. The plasmid containing
Ucp1 -6kb enhancer in pGL4 was described before (Emmett et al., 2017). The start
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of the enhancer (331 bases total) is located 5964 bases upstream of the Ucp1 start
site. De novo motif analyses were performed using JASPAR. The Ucp1-6kb
mutant enhancer was constructed by digesting the Ucp1-6kb enhancer with AvrII
(NEB) and BglII (NEB), and inserting a 51 bp annealed oligonucleotide synthesized
with the ERR binding site deleted. pRL-CMV was used for internal normalization
of luciferase assays. The EBF2 R162A DNA binding mutant was generated by sitedirected PCR mutagenesis and designed using homology from EBF1 (Fields et al.,
2008). The C-terminal domain mutant form of EBF2 was generated by PCR to
encode only the N-terminal 421 amino acids of the wildtype protein (by analogy to
EBF1) (Boller et al., 2016). Expression plasmids (pcDNA-PGC1a, pcDNA-ERRa,
pcDNA-EBF2, pcDNA-EBF1, pcDNA-EBF2, pcDNA-EBF3, pcDNA-PPARg, and
pcDNA-RXRa) were described before (Emmett et al., 2017; Rajakumari et al.,
2013). Plasmids were transfected into NIH 3T3 cells with Lipofectamine 2000
(Invitrogen). 48 hours following transfection, cells were harvested in passive lysis
buffer and dual luciferase assay was performed (Promega E1910) with a Synergy
plate reader (BioTek). For CRISPR experiments, gRNA constructs were designed
using CRISPOR and cloned into lentiCRISPR v2 as described previously
(Haeussler et al., 2016; Shapira et al., 2017). Two gRNAs against each
experimental target were co-infected to create mutant cell lines.

DATA AND CODE AVAILABILITY
The accession number for the high throughput sequencing data sets (ChiPseq and
RNAseq) reported in this paper is GEO: GSE144188.
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QUANTIFICATION AND STATISTICAL ANALYSIS
No power calculations were performed prior to initiation of the study. No mice were
omitted from the study. All individual data points were plotted to assay normality.
Two sample T tests were performed where comparisons between two groups were
being assayed. One way ANOVAs with pairwise comparisons corrected with the
Holm Sidak method were performed where comparisons between more than two
groups were being assayed. One-way repeated measure ANOVAs with pairwise
comparisons corrected with the Holm Sidak method were performed where
comparisons between more than two groups and repeated measures were being
assayed. # indicates p-value <0.1; * indicates p-value <0.05, ** indicates p-value
<0.01, *** indicates p-value <0.001, **** indicates p-value <0.0001.

118

Corresponding to Chapter 3:
Adapted from: Angueira AR*, Sakers AP*, cheng L, Shrestha R, Okada C, Batmanov K,
Susztak K, and Seale P. Defining the lineage of thermogenic perivascular adipose tissue.
Biorxiv. 2020
Mice:
Mice were housed under the care of University of Pennsylvania University Laboratory
Animal Resources (ULAR), which provides both basic husbandry and veterinary care.
Animals were raised at room temperature on standard chow with a 12-hour light/dark
cycle. All mouse housing and husbandry occurred at RT (22oC) unless specified
otherwise. For thermoneutral acclimation, 4- to 5-week old mice were housed at 30oC for
one month. For chronic cold exposure, 8- to 10-week-old mice were pair-housed in cages
at 4oC for one week. Mice were fed a western diet composed of 40% fat and 0.15%
cholesterol from Research Diets (D12079B). Tamoxifen (Sigma [T5648], stock 20 mg/mL
in corn oil) was intraperitoneally injected at a dose of 100 mg/kg for one day or five
consecutive days. Mice were treated with rosiglitazone (250 nMoles/d) (Cayman catalog
#11884) for the experimental time course indicated in text. Experiments performed on
embryonic and perinatal mice were conducted on male and female mice. Experiments at
adult time points were performed in male and female mice between the ages of 8 to 12
weeks at the onset of the experiment.

C57/Bl6N

(RRID:IMSR_TAC:B6)

mice

were

obtained

from

Taconic.

CD1

(RRID:IMSR_CRL:024) mice were obtained from Charles River. The following strains
were obtained from the Jackson Laboratory: mTmG (strain name: B6.129(Cg)Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J, RRID:IMSR_JAX:007676), tdTom (strain name:
B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J, RRID:IMSR_JAX:007914), Myh11-Cre (strain
name: B6.Cg-Tg(Myh11-cre,-EGFP)2Mik/J, RRID:IMSR_JAX:007742), Pdgfra-CreER
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(strain name:

B6.129S-Pdgfratm1.1(cre/ERT2)Blh/J, RRID:IMSR_JAX:032770), Gli1-CreER

(strain name: Gli1tm3(cre/ERT2)Alj/J, RRID:IMSR_JAX:007913), Penk-Cre (strain name:
B6;129S-Penktm2(cre)Hze/J, RRID:IMSR_JAX:025112), and Vipr2-Cre (strain name: B6.CgVipr2em1.1(cre)Hze/J, RRID:IMSR_JAX:031332). The following stock was generated by
Patrick Seale: AdipoqCre; Ebf2 loxP/loxP (Angueira et al., 2020).

Histology and Immunofluorescence
Tissues were fixed in 4% PFA overnight, washed in PBS, dehydrated in ethanol, paraffinembedded and sectioned. For en bloc retroperitoneal sections, perinatal mice were
euthanized by decapitation, the thoracic viscera were removed, and the tissue was placed
in 4% PFA overnight. Adult mice were perfused with 5 mL of 4% PFA and tissues were
harvested as above. Slides were deparaffinized and heat-antigen retrieved in Bulls Eye
Decloaking buffer (Biocare). Slides were incubated in indicated primary antibodies
overnight, stained with secondary antibody, and developed with Tyramide Signal
Amplification (TSA, Akoya Biosciences). Primary antibodies used for staining were:
PERILIPIN: (1:200, CST: 3470, RRID:AB_2167268), PDGFRA: (1:50, Novus Biologicals:
AF1062, RRID:AB_2236897), MYH11: (1:100, Abcam: ab53219, RRID:AB_2147146),
PPARG: (1:500, Invitrogen: MA5-14889, RRID:AB_10985650), RFP: (1:250, VWR
Scientific,

600-401-379,

RRID:AB_2209751),

GFP

(1:500,

Abcam:

AB6673,

RRID:AB_305643), CD200: (1:25, Novus Biologicals: AF2724, RRID:AB_416669),
ACTA2: Sigma: (1:200, A2547, RRID:AB_476701), TAGLN: (1:100, Abcam: ab10135,
RRID:AB_2255631), and DAPI (1:1000 Roche). RNA in situ hybridizations were
performed using the RNAscope system (Advanced Cell Diagnostics; 323100, 323120)
with the following probes: Bace2 (407151), Clec11a (583301), Pi16 (451311-C2), and
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Ly6a (427571-C2). Images were captured on a Leica TCS SP8 confocal microscope or
Keyence inverted microscope.

RNA Extraction, qRT-PCR and RNA Sequencing analysis
Total RNA was extracted using TRIzol (Invitrogen) and Purelink RNA columns (Fisher).
For processing of RNA from cultured primary adipocytes, RNA was extracted using Trizol
(Invitrogen) combined with PicoPure RNA Isolation Kit (Fisher). mRNA was reverse
transcribed into cDNA using the ABI High-Capacity cDNA Synthesis kit (ABI). Real-time
PCR was performed on an ABI7900HT PCR machine using SYBR green fluorescent dye
(Applied Biosystems). Fold changes were calculated using the

CT method, with Tata

Binding Protein (Tbp) mRNA serving as a normalization control. RNA sequencing from
sorted progenitors was performed at Genewiz with the following procedure. RNA was
extracted using Trizol LS (Invitrogen) and quantified using Qubit and TapeStation. RNA
sequencing libraries were made using the SMART-Seq v4 Ultra Low Input Kit. Samples
were sequenced on an Illumina HiSeq with a 2x150 Paired End (PE) configuration.
FASTQ files were aligned to mm10 using STAR (2.5.2a) with quantMode =
GeneCounts. The unstranded genecounts for each sample were analyzed for differential
gene expression using the R (3.6.3) package DESeq2 (1.26.0). In general, for each
experiment involving an RNA seq dataset, the DESeq2 model was built with the design
(~CellType) where “CellType” refers to the different sorted populations, with all CellTypes
included in the model. Pairwise differential expression was calculated using the DESeq2
function “results” with thresholds of alpha=0.1. Log2 Fold change thresholds were used
as indicated. ENSEMBLID’s were converted to gene symbols using the R package
org.Mm.eg.db (3.10.0). Pathway analysis was performed via WikiPathways with
annotations for Mus Musculus using the package clusterProfiler (3.13.3) and
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rWikiPathways (1.6.1) (Figures 4 and 6). Pathway analysis was performed using Enrichr
WikiPathways 2019 Mouse for Figure 3.
Heatmaps represent either Log2 fold change versus row mean or row score as
indicated as indicated. Underlying data for heatmaps came from the DESeq2 regularized
log transform of the normalized count values using the DESeq2 function “rlog”. Figures
showing side by side scRNA-seq and bulk RNA seq heatmaps contain the exact same
genes in the same order on both heatmaps.
scRNA Seq
Single cells were isolated from dissected aortas and flow sorted to isolate live (DAPI-)
cells and remove debris. Cells were collected as either CD45+ (immune) and CD45- (nonimmune) cells. For adult single cell RNA Sequencing, CD45+ cells were mixed with CD45cells to achieve a proportion of ~20%. Single cell transcriptomes were collected as
described previously using the 10X Genomics platform with v2 (perinatal) and v3 (adult)
chemistry (10× Genomics, Pleasanton, CA) (Merrick et al., 2019). The libraries were
sequenced using an Illumina HiSeq 4000. The reads were processed using the
CellRanger pipeline and R Studio using Seuratv3 (Merrick et al., 2019, Stuart et al., 2019).
Cells were filtered based on their expression of a minimum number of genes (E18/P3: 500
< nFeatureRNA < 3000; Adult: 250 < nFeature RNA < 4000) and mitochondrial genome
(<10%) abundance for each dataset individually. Regression was performed using
ScaleData function for the following variables: percentage of mitochondrial reads and cell
cycle phase (G2M.Score/S.Score). Dimensionality reduction was performed in Seurat
using UMAP and differential gene expression between clusters was performed using
FindMarkers function. For all datasets, immune cells were collapsed into one cluster for
simplicity. For the perinatal dataset, two clusters of mesothelial cells were collapsed to
generate one mesothelial cluster. For the adult dataset, initial clustering revealed that
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SMC population 1 separated into two clusters, but the effect size of gene expression
between the two groups was small, so they were collapsed to form SMC population 1.
Feature-plots, dot-plots and heat-maps were generated using Seurat.

E18/P3 combined analysis
Dataset integration was performed using the Seurat functions FindIntegrationAnchors
followed by IntegrateData. Scaling and regression were performed using the Seurat
ScaleData function for the following variables: percentage of mitochondrial reads and cell
cycle phase (G2M.Score/S.Score). Dimensionality reduction was performed in Seurat
using UMAP and differential gene expression between clusters was performed using
FindMarkers function. For all datasets, immune cells were collapsed into one cluster for
simplicity. Single gene UMAP feature plots showing expression of select genes at E18
and P3 were generated for the RNA assay using a modified version of the Seurat
FeaturePlot function. (This modified version plots both the E18 and P3 UMAPs on the
same color/expression scale, while the default Seurat function does not).

Generation of single cell suspensions from aorta
Aorta were isolated from mice, minced and placed into digestion medium (DMEM,
Collagenase D: 6.1mg/ml (Roche), Dispase II: 2.4 mg/ml (Roche) and placed at 37oC with
constant agitation at 200 rpm. To enrich for cell populations with differential sensitivity to
digestion, we utilized the following procedures. For embryonic/newborn mice, 20% of the
digestion was quenched at 15 minutes, 20% at 20 minutes and the remaining 60% at 25
minutes (embryos/perinatal). For adult aortas 50% of the digestion was quenched at 30
minutes, 50% at 60 minutes. For stripped aorta flow cytometry analysis, perivascular
adipose tissue was removed from the aorta and digested separately from the cleaned
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aorta. Tissue digestions were quenched with an equal volume of complete medium
(DMEM/10% FBS). Dissociated cells were suspended using a P1000 pipette and filtered
through a 100

m filter. Cells were then pelleted at 400 g for 4 min and RBCs were lysed

in 155mM NH4Cl, 12mM NaHCO3, and 0.1mM EDTA for 4 min. An equal volume of
complete medium was added and the cells were filtered through a 40um filter for
downstream analyses.

Flow Cytometry and Sorting:
Isolated cells were suspended in FACS buffer (HBSS, 3% 0.45uM filtered FBS; Fischer).
Cells were stained in FACS buffer with antibodies (see below) for 1 hr at 4oC in the dark.
Cells were washed 2x with cold FACS buffer and sorted on a BD FACS Aria cell sorter
(BD Bioscences) with a 100

m nozzle as previously described (Merrick et al., 2019). All

compensation was performed at the time of acquisition in BD FACS DIVA software using
single stained cells or compensation beads (BioLegend catalog no. A10497). The
following antibodies were used for FACS protocols. P3 Aorta: LY6A-BV711 (1:100
Biolegend-108131 RRID:AB_2562241),CD317-PerCp-Cy5.5 (1:100 Biolegend-127022
RRID:AB_2566647), CD200-AF488 (1:100 Biorad-MCA1958A488), CD45-APC/Cy7
(1:1000, Biolegend-103115 RRID:AB_312980), CD31-APC/Fire750 (1:1000 Biolegend102528

RRID:AB_2721491),

Ter119-APC/Cy7

(1:1000

Biolegend

116223

RRID_AB:2137788), CD142-CF647 (1:1000 Sino Biological), FVS510 (1:1000 BD
Biosciences

654406).

P3

iWAT:

CD45-APC/Cy7

(1:1000,

Biolegend-103115

RRID:AB_312980), CD31-APC/Fire750 (1:1000 Biolegend-102528 RRID:AB_2721491),
CD142-CF647 (1:1000 Sino Biological), CD26(DPP4)-FITC (Biolegend, San Diego, CA,
cat# 302704 1:100); ICAM1-PE/Cy7 (Biolegend cat# 353116 1:100). Adult Aorta: CD200AF488 (1:100 Biorad-MCA1958A488), CD45-APC/Cy7 (1:1000, Biolegend-103115
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RRID:AB_312980), CD31-APC/Fire750 (1:1000 Biolegend-102528 RRID:AB_2721491),
Ter119-APC/Cy7 (1:1000 Biolegend 116223 RRID_AB:2137788), MCAM-PerCP/Cy5.5
(1:100 Biolegend 134709 RRID:AB_11204083), PDGFRa-PE/Cy7 (1:200 Biolegend
135912 RRID:AB_2715974), and DAPI (1:10000 Roche 10236276001).

Cell Culture:
Sort-purified cells were plated on 384-well Cellbind plates (Sigma-Aldrich catalog no.
CLS3770) and cultured in DMEM/F12 supplemented with 10% FBS and Primocin (50
ug/mL). Cells were plated at a density of 10,000-30,000 cells per well and induced to
differentiate into adipocytes within 3 days of initial plating. Cell density and time until
differentiation was kept consistent within each experiment. Adipogenic differentiation
cocktail consisted of 1 μM dexamethasone (Sigma catalog no. D4902), 0.5 μM
isobutylmethylxanthine (Sigma catalog no. I7018), 125 nM indomethacin, 20 nM insulin,
and 1 nM T3 for 48 hours. Following two days of induction, media was changed to 20 nM
insulin and 1 nM T3. Medium was changed every two days for six more days.

Adipogenesis Assays and Quantification:
Adipogenesis was assessed by staining with Bodipy 493/503 (Invitrogen catalog no.
D3922) for lipid accumulation and Hoechst 33342 (Thermo Fisher catalog no. 62249) for
nuclei, as described previously (Merrick et al., 2019). Briefly, cells were differentiated in
384 well tissue culture plates (Sigma-Aldrich catalog no. CLS3770), fixed with 4%
paraformaldehyde, stained, and imaged on a Keyence inverted microscope (BZX-710)
with the following filters: DAPI (ex, 360/40 nm; em, 460/50 nm; Keyence, OP-87762) and
GFP (ex, 470/40 nm; em, 525/50 nm; Keyence, OP-87763) filters. Images were acquired
at 20x in a 7x7 tiled grid and stitched to capture the entirety of each well. Tiling and
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stitching were performed with Keyence BZ-X Viewer software. Image quantification was
performed automatically in ImageJ using a macro which: 1) Split images into component
channels, 2a) for the nuclei channel applied a 3-Sigma Gaussian blur, performed
thresholding to identify signal above background, performed watershed to segmentation,
and counted the number of nuclei, 2b) for the lipid channel applied a 2-Sigma Gaussian
blurm performed thresholding to identify signal above background, and counted the area
(#of pixels) with signal above threshold. The amount of adipogenesis was calculated as
Lipid Area/#nuclei.

Statistical Analysis:
No power calculations were performed prior to initiation of the study. No mice were omitted
from the study. All individual data points were plotted to assay normality. Experiments
from a common pool of digested tissue or independent pools processed separately are
indicated in the text. Two sample t tests were performed where comparisons between two
groups were being assayed. One way ANOVAs with pairwise comparisons corrected with
the Holm Sidak method were used for comparisons between more than two groups. Two
way ANOVAs with multiple comparisons corrected with the Holm Sidak method were
performed for adipogenesis experiments (within each experimental day compare between
cell types). # indicates p value < 0.1; * indicates p value < 0.05, ** indicates p value < 0.01,
*** indicates p value < 0.001, **** indicates p value < 0.0001.
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